MetaADEDB 2.0 @ LMMD
Glatiramer Acetate
(FHEAIOHRHQGZPC-KIWGSFCNSA-N)
Structure
SMILES
OC(=O)[C@H](Cc1ccc(cc1)O)N.C[C@@H](C(=O)O)N.OC(=O)CC[C@@H](C(=O)O)N.CC(=O)O.NCCCC[C@@H](C(=O)O)N
Molecular Formula:
C25H45N5O13
Molecular Weight:
623.651
Log P:
2.1476
Hydrogen Bond Acceptor:
18
Hydrogen Bond Donor:
12
TPSA:
374.13
CAS Number(s):
147245-92-9
Synonym(s)
1.
Glatiramer Acetate
2.
Copaxone
3.
Glatiramer
4.
TV 5010
5.
TV-5010
6.
TV5010
7.
5010, TV
8.
Acetate, Glatiramer
External Link(s)
MeSHD000068717
PubChem Compound3081884
Adverse Drug Event(s)
NameNumber of ReportsReference(s)Data Source
1Injection site painFAERS: 3015
Canada Vigilance: 9
Canada Vigilance
US FAERS
2Multiple sclerosis relapseFAERS: 2505
Canada Vigilance: 7
Canada Vigilance
OFFSIDES
US FAERS
3Injection Site ReactionFAERS: 2126
Canada Vigilance: 7
Canada Vigilance
US FAERS
4Drug ineffectiveFAERS: 1726
Canada Vigilance: 4
Canada Vigilance
OFFSIDES
US FAERS
5Injection site erythemaFAERS: 1321
Canada Vigilance: 5
Canada Vigilance
OFFSIDES
US FAERS
6Injection site massFAERS: 1180OFFSIDES
US FAERS
7Multiple SclerosisFAERS: 1167
Canada Vigilance: 4
12432978
23517930
CTD
OFFSIDES
Canada Vigilance
US FAERS
8FatigueFAERS: 1080
Canada Vigilance: 3
Canada Vigilance
OFFSIDES
US FAERS
9UrticariaFAERS: 988
Canada Vigilance: 5
Canada Vigilance
US FAERS
10PainFAERS: 821
Canada Vigilance: 3
Canada Vigilance
OFFSIDES
US FAERS
11Injection site pruritusFAERS: 809
Canada Vigilance: 2
Canada Vigilance
OFFSIDES
US FAERS
12HypersensitivityFAERS: 698
Canada Vigilance: 5
Canada Vigilance
US FAERS
13NauseaFAERS: 685
Canada Vigilance: 5
Canada Vigilance
OFFSIDES
US FAERS
14ChillsFAERS: 678
Canada Vigilance: 5
Canada Vigilance
US FAERS
15Injection site bruisingFAERS: 678
Canada Vigilance: 4
Canada Vigilance
US FAERS
16FlushingFAERS: 673
Canada Vigilance: 6
Canada Vigilance
US FAERS
17Injection site urticariaFAERS: 668OFFSIDES
US FAERS
18DizzinessFAERS: 658
Canada Vigilance: 5
Canada Vigilance
OFFSIDES
US FAERS
19HeadacheFAERS: 598
Canada Vigilance: 3
Canada Vigilance
US FAERS
20Chest PainFAERS: 535
Canada Vigilance: 1
Canada Vigilance
OFFSIDES
US FAERS
21PruritusFAERS: 511
Canada Vigilance: 3
Canada Vigilance
US FAERS
22TremorFAERS: 498
Canada Vigilance: 6
Canada Vigilance
US FAERS
23MalaiseFAERS: 488
Canada Vigilance: 3
Canada Vigilance
US FAERS
24Chest discomfortFAERS: 487
Canada Vigilance: 7
Canada Vigilance
US FAERS
25AstheniaFAERS: 475
Canada Vigilance: 1
Canada Vigilance
OFFSIDES
US FAERS
26Immediate post-injection reactionFAERS: 468
Canada Vigilance: 5
Canada Vigilance
OFFSIDES
US FAERS
27PalpitationsFAERS: 459
Canada Vigilance: 5
Canada Vigilance
US FAERS
28VomitingFAERS: 458
Canada Vigilance: 10
Canada Vigilance
US FAERS
29ErythemaFAERS: 447
Canada Vigilance: 11
Canada Vigilance
OFFSIDES
US FAERS
30Adverse eventFAERS: 444OFFSIDES
US FAERS
31Feeling abnormalFAERS: 368
Canada Vigilance: 1
Canada Vigilance
OFFSIDES
US FAERS
32AnxietyFAERS: 366
Canada Vigilance: 1
Canada Vigilance
OFFSIDES
US FAERS
33Central nervous system lesionFAERS: 336OFFSIDES
US FAERS
34Drug dose omissionFAERS: 322US FAERS
35Back PainFAERS: 299
Canada Vigilance: 2
Canada Vigilance
US FAERS
36Injection site necrosisFAERS: 262
Canada Vigilance: 4
Canada Vigilance
US FAERS
37AlopeciaFAERS: 237
Canada Vigilance: 1
Canada Vigilance
OFFSIDES
US FAERS
38ArthralgiaFAERS: 207US FAERS
39Injection site warmthFAERS: 206
Canada Vigilance: 1
Canada Vigilance
OFFSIDES
US FAERS
40Memory impairmentFAERS: 204
Canada Vigilance: 1
Canada Vigilance
US FAERS
41SwellingFAERS: 202US FAERS
42Injection site atrophyFAERS: 200
Canada Vigilance: 7
Canada Vigilance
OFFSIDES
US FAERS
43Visual ImpairmentFAERS: 198
Canada Vigilance: 3
Canada Vigilance
US FAERS
44Anaphylactic shockFAERS: 195
Canada Vigilance: 1
Canada Vigilance
US FAERS
45Burning sensationFAERS: 184
Canada Vigilance: 1
Canada Vigilance
US FAERS
46LipoatrophyFAERS: 175
Canada Vigilance: 3
Canada Vigilance
US FAERS
47Urinary tract infectionFAERS: 166US FAERS
48NasopharyngitisFAERS: 163US FAERS
49treatment failureFAERS: 160US FAERS
50Maternal exposure during pregnancyFAERS: 151US FAERS
51Feeling ColdFAERS: 148
Canada Vigilance: 2
Canada Vigilance
OFFSIDES
US FAERS
52Myocardial InfarctionFAERS: 145US FAERS
53Optic NeuritisFAERS: 143
Canada Vigilance: 1
Canada Vigilance
OFFSIDES
US FAERS
54Wrong technique in product usage processFAERS: 142
Canada Vigilance: 1
Canada Vigilance
US FAERS
55SyncopeFAERS: 136
Canada Vigilance: 3
Canada Vigilance
US FAERS
56PneumoniaFAERS: 134
Canada Vigilance: 1
Canada Vigilance
US FAERS
57Peripheral swellingFAERS: 132
Canada Vigilance: 1
Canada Vigilance
US FAERS
58Therapy changeFAERS: 131US FAERS
59Injection site irritationFAERS: 128OFFSIDES
US FAERS
60AbasiaFAERS: 127OFFSIDES
US FAERS
61Weight decreasedFAERS: 127US FAERS
62Musculoskeletal stiffnessFAERS: 126
Canada Vigilance: 1
Canada Vigilance
US FAERS
63MyalgiaFAERS: 126
Canada Vigilance: 1
Canada Vigilance
US FAERS
64Lip swellingFAERS: 125
Canada Vigilance: 5
Canada Vigilance
US FAERS
65LymphadenopathyFAERS: 120
Canada Vigilance: 4
Canada Vigilance
US FAERS
66Injection site scarFAERS: 115OFFSIDES
US FAERS
67Therapy cessationFAERS: 112US FAERS
68InfluenzaFAERS: 109US FAERS
69Abdominal PainFAERS: 106
Canada Vigilance: 4
Canada Vigilance
OFFSIDES
US FAERS
70TachycardiaFAERS: 106
Canada Vigilance: 1
Canada Vigilance
US FAERS
71DysgeusiaFAERS: 104
Canada Vigilance: 2
Canada Vigilance
OFFSIDES
US FAERS
72PregnancyFAERS: 100US FAERS
73Skin reactionFAERS: 99US FAERS
74Incorrect dose administered by deviceFAERS: 96US FAERS
75Product quality issueFAERS: 94
Canada Vigilance: 1
Canada Vigilance
OFFSIDES
US FAERS
76Product substitution issueFAERS: 94US FAERS
77Cerebrovascular accidentFAERS: 90US FAERS
78Device malfunctionFAERS: 90US FAERS
79Incorrect dose administeredFAERS: 90US FAERS
80Needle issueFAERS: 90US FAERS
81BlindnessFAERS: 89US FAERS
82VertigoFAERS: 89
Canada Vigilance: 1
Canada Vigilance
US FAERS
83DehydrationFAERS: 87
Canada Vigilance: 1
Canada Vigilance
US FAERS
84DiplopiaFAERS: 84OFFSIDES
US FAERS
85InfectionFAERS: 83
Canada Vigilance: 1
Canada Vigilance
OFFSIDES
US FAERS
86Injection site discomfortFAERS: 81OFFSIDES
US FAERS
87Product dose omissionFAERS: 81US FAERS
88StressFAERS: 81OFFSIDES
US FAERS
89Injection site inflammationFAERS: 79
Canada Vigilance: 1
Canada Vigilance
OFFSIDES
US FAERS
90Limb discomfortFAERS: 75OFFSIDES
US FAERS
91Injection site noduleFAERS: 74OFFSIDES
US FAERS
92NecrosisFAERS: 74
Canada Vigilance: 2
Canada Vigilance
US FAERS
93Injection site vesiclesFAERS: 73OFFSIDES
US FAERS
94CellulitisFAERS: 72
Canada Vigilance: 1
Canada Vigilance
OFFSIDES
US FAERS
95Injection site infectionFAERS: 72
Canada Vigilance: 4
Canada Vigilance
OFFSIDES
US FAERS
96Disease ProgressionFAERS: 71
Canada Vigilance: 1
Canada Vigilance
OFFSIDES
US FAERS
97Inappropriate schedule of drug administrationFAERS: 68US FAERS
98HemiparesisFAERS: 67OFFSIDES
US FAERS
99DysarthriaFAERS: 66US FAERS
100Urinary IncontinenceFAERS: 65US FAERS
101Muscle tightnessFAERS: 64OFFSIDES
US FAERS
102Respiratory arrestFAERS: 64
Canada Vigilance: 2
Canada Vigilance
US FAERS
103Abdominal discomfortFAERS: 63
Canada Vigilance: 1
Canada Vigilance
OFFSIDES
US FAERS
104Injection site extravasationFAERS: 63US FAERS
105DiscomfortFAERS: 61US FAERS
106HypotensionFAERS: 61US FAERS
107Neck PainFAERS: 61
Canada Vigilance: 1
Canada Vigilance
US FAERS
108PresyncopeFAERS: 61
Canada Vigilance: 2
Canada Vigilance
US FAERS
109Incorrect route of drug administrationFAERS: 60OFFSIDES
US FAERS
110Live BirthFAERS: 60US FAERS
111Product use issueFAERS: 60US FAERS
112SomnolenceFAERS: 60US FAERS
113AmnesiaFAERS: 59
Canada Vigilance: 2
Canada Vigilance
OFFSIDES
US FAERS
114DemyelinationFAERS: 59OFFSIDES
US FAERS
115Muscle SpasticityFAERS: 59
Canada Vigilance: 1
Canada Vigilance
US FAERS
116Progressive multiple sclerosisFAERS: 59US FAERS
117SinusitisFAERS: 55US FAERS
118Eye painFAERS: 54US FAERS
119Injection site injuryFAERS: 54US FAERS
120Injection related reactionFAERS: 53US FAERS
121Injury associated with deviceFAERS: 52US FAERS
122LymphomaFAERS: 52
Canada Vigilance: 1
Canada Vigilance
OFFSIDES
US FAERS
123ThrombosisFAERS: 51US FAERS
124AphasiaFAERS: 50US FAERS
125Oropharyngeal painFAERS: 50US FAERS
126SepsisFAERS: 50
Canada Vigilance: 2
Canada Vigilance
US FAERS
127Lipodystrophy acquiredFAERS: 49OFFSIDES
US FAERS
128Bone painFAERS: 47US FAERS
129ConstipationFAERS: 45US FAERS
130Joint swellingFAERS: 44US FAERS
131Musculoskeletal PainFAERS: 44US FAERS
132Diabetes MellitusFAERS: 43US FAERS
133ChokingFAERS: 42US FAERS
134Depressed moodFAERS: 42US FAERS
135BronchitisFAERS: 41US FAERS
136Device leakageFAERS: 41US FAERS
137General physical health deteriorationFAERS: 41OFFSIDES
US FAERS
138NephrolithiasisFAERS: 41US FAERS
139NervousnessFAERS: 41US FAERS
140NeuralgiaFAERS: 41OFFSIDES
US FAERS
141AngioedemaFAERS: 40
Canada Vigilance: 1
Canada Vigilance
OFFSIDES
US FAERS
142CyanosisFAERS: 39
Canada Vigilance: 2
Canada Vigilance
OFFSIDES
US FAERS
143Gait inabilityFAERS: 39US FAERS
144Skin necrosisFAERS: 39
Canada Vigilance: 1
Canada Vigilance
OFFSIDES
US FAERS
145CryingFAERS: 38US FAERS
146CystitisFAERS: 38
Canada Vigilance: 1
Canada Vigilance
US FAERS
147Post procedural complicationFAERS: 38OFFSIDES
US FAERS
148White blood cell count decreasedFAERS: 38
Canada Vigilance: 1
Canada Vigilance
US FAERS
149Drug exposure during pregnancyFAERS: 37OFFSIDES
US FAERS
150Pulmonary EmbolismFAERS: 36
Canada Vigilance: 1
Canada Vigilance
US FAERS
151Skin irritationFAERS: 36US FAERS
152Walking aid userFAERS: 36US FAERS
153AsthmaFAERS: 35OFFSIDES
US FAERS
154Cold sweatFAERS: 35OFFSIDES
US FAERS
155PancreatitisFAERS: 35
Canada Vigilance: 1
Canada Vigilance
OFFSIDES
US FAERS
156Product storage errorFAERS: 35US FAERS
157Rash erythematousFAERS: 35
Canada Vigilance: 1
Canada Vigilance
US FAERS
158TinnitusFAERS: 35OFFSIDES
US FAERS
159Head discomfortFAERS: 34US FAERS
160Cardiac ArrestFAERS: 33
Canada Vigilance: 2
Canada Vigilance
US FAERS
161Injection site hypersensitivityFAERS: 33OFFSIDES
US FAERS
162Injection site indentationFAERS: 33US FAERS
163ArthritisFAERS: 32US FAERS
164AsphyxiaFAERS: 32US FAERS
165Drug administered in wrong deviceFAERS: 32US FAERS
166InflammationFAERS: 32US FAERS
167LethargyFAERS: 32OFFSIDES
US FAERS
168PallorFAERS: 32
Canada Vigilance: 2
Canada Vigilance
OFFSIDES
US FAERS
169Wrong technique in device usage processFAERS: 32US FAERS
170Injection site scabFAERS: 31OFFSIDES
US FAERS
171PhotophobiaFAERS: 31US FAERS
172IncontinenceFAERS: 30OFFSIDES
US FAERS
173Accidental exposure to productFAERS: 29US FAERS
174Disease recurrenceFAERS: 29US FAERS
175HemiplegiaFAERS: 29OFFSIDES
US FAERS
176ShockFAERS: 29US FAERS
177HysterectomyFAERS: 28OFFSIDES
US FAERS
178Injection site cellulitisFAERS: 28
Canada Vigilance: 1
Canada Vigilance
US FAERS
179Insurance issueFAERS: 28US FAERS
180Skin lesionFAERS: 28OFFSIDES
US FAERS
181AcneFAERS: 27US FAERS
182DeafnessFAERS: 27US FAERS
183Wrong technique in drug usage processFAERS: 27OFFSIDES
US FAERS
184DisorientationFAERS: 26US FAERS
185Exposure during breast feedingFAERS: 26US FAERS
186HypokinesiaFAERS: 26
Canada Vigilance: 1
Canada Vigilance
US FAERS
187LacerationFAERS: 26US FAERS
188Needle fatigueFAERS: 26US FAERS
189Skin UlcerFAERS: 26US FAERS
190Drug effect incompleteFAERS: 25US FAERS
191Dry skinFAERS: 25US FAERS
192EpilepsyFAERS: 25OFFSIDES
US FAERS
193ScabFAERS: 25OFFSIDES
US FAERS
194Trigeminal NeuralgiaFAERS: 25US FAERS
195Unresponsive to stimuliFAERS: 25OFFSIDES
US FAERS
196Ankle FractureFAERS: 24OFFSIDES
US FAERS
197Choking sensationFAERS: 24OFFSIDES
US FAERS
198nervous system disorderFAERS: 24US FAERS
199Apparent deathFAERS: 23US FAERS
200BedriddenFAERS: 23US FAERS
201Cardiac FlutterFAERS: 23US FAERS
202DyspepsiaFAERS: 23OFFSIDES
US FAERS
203Emotional disorderFAERS: 23US FAERS
204Joint stiffnessFAERS: 23US FAERS
205Suicide attemptFAERS: 23US FAERS
206Unevaluable eventFAERS: 23US FAERS
207Drug administration errorFAERS: 22US FAERS
208Therapeutic response unexpectedFAERS: 22OFFSIDES
US FAERS
209DisabilityFAERS: 21US FAERS
210Injection site abscessFAERS: 21US FAERS
211JC virus test positiveFAERS: 21US FAERS
212Limb injuryFAERS: 21US FAERS
213Temperature intoleranceFAERS: 21US FAERS
214Urinary RetentionFAERS: 21US FAERS
215Wheelchair userFAERS: 21OFFSIDES
US FAERS
216Alanine Aminotransferase IncreasedFAERS: 20OFFSIDES
US FAERS
217ArthropathyFAERS: 20US FAERS
218Band sensationFAERS: 20US FAERS
219Deep Vein ThrombosisFAERS: 20
Canada Vigilance: 1
Canada Vigilance
US FAERS
220Loss of personal independence in daily activitiesFAERS: 20US FAERS
221Respiratory distressFAERS: 20US FAERS
222Atrial FibrillationFAERS: 19
Canada Vigilance: 1
Canada Vigilance
US FAERS
223Blood glucose increasedFAERS: 19US FAERS
224CholelithiasisFAERS: 19US FAERS
225DysphoniaFAERS: 19US FAERS
226Intestinal ObstructionFAERS: 19
Canada Vigilance: 1
Canada Vigilance
OFFSIDES
US FAERS
227Respiratory FailureFAERS: 19US FAERS
228Therapy non-responderFAERS: 19OFFSIDES
US FAERS
229Uterine CancerFAERS: 19OFFSIDES
US FAERS
230Wrong device usedFAERS: 19US FAERS
231Blood potassium decreasedFAERS: 18US FAERS
232MonoplegiaFAERS: 18US FAERS
233Mood swingsFAERS: 18US FAERS
234Mouth swellingFAERS: 18US FAERS
235Night sweatsFAERS: 18US FAERS
236Syringe issueFAERS: 18US FAERS
237Throat irritationFAERS: 18US FAERS
238jaundiceFAERS: 18US FAERS
239AngerFAERS: 17OFFSIDES
US FAERS
240Blood glucose decreasedFAERS: 17US FAERS
241DementiaFAERS: 17US FAERS
242DysuriaFAERS: 17US FAERS
243Facial PainFAERS: 17US FAERS
244Mental impairmentFAERS: 17
Canada Vigilance: 1
Canada Vigilance
US FAERS
245OsteoporosisFAERS: 17US FAERS
246Thermal burnFAERS: 17US FAERS
247WheezingFAERS: 17US FAERS
248Ectopic PregnancyFAERS: 16US FAERS
249Injection site ulcerFAERS: 16OFFSIDES
US FAERS
250JC virus infectionFAERS: 16US FAERS
251Joint injuryFAERS: 16US FAERS
252Product packaging issueFAERS: 16US FAERS
253StillbirthFAERS: 16US FAERS
254AbscessFAERS: 15
Canada Vigilance: 1
Canada Vigilance
OFFSIDES
US FAERS
255Autoimmune hepatitisFAERS: 15OFFSIDES
US FAERS
256Clostridium difficile infectionFAERS: 15US FAERS
257NeutropeniaFAERS: 15
Canada Vigilance: 1
Canada Vigilance
US FAERS
258Nonspecific reactionFAERS: 15
Canada Vigilance: 1
Canada Vigilance
OFFSIDES
US FAERS
259Product physical issueFAERS: 15US FAERS
260Rheumatoid ArthritisFAERS: 15US FAERS
261SarcoidosisFAERS: 15
Canada Vigilance: 1
Canada Vigilance
OFFSIDES
US FAERS
262SneezingFAERS: 15US FAERS
263Tooth LossFAERS: 15US FAERS
264AppendicitisFAERS: 14
Canada Vigilance: 1
Canada Vigilance
US FAERS
265Aspartate Aminotransferase IncreasedFAERS: 14US FAERS
266Bipolar DisorderFAERS: 14US FAERS
267CataractFAERS: 14US FAERS
268Depressed Level of ConsciousnessFAERS: 14US FAERS
269Facial paralysisFAERS: 14US FAERS
270HypersomniaFAERS: 14US FAERS
271ImmunosuppressionFAERS: 14OFFSIDES
US FAERS
272Pancreatic carcinomaFAERS: 14US FAERS
273Product use in unapproved indicationFAERS: 14US FAERS
274ThirstFAERS: 14US FAERS
275Transaminases increasedFAERS: 14OFFSIDES
US FAERS
276DysgraphiaFAERS: 13OFFSIDES
US FAERS
277FormicationFAERS: 13OFFSIDES
US FAERS
278HyperpyrexiaFAERS: 13
Canada Vigilance: 1
Canada Vigilance
US FAERS
279No adverse eventFAERS: 13US FAERS
280Pain of skinFAERS: 13US FAERS
281Thyroid NeoplasmFAERS: 13US FAERS
282Activities of daily living impairedFAERS: 12US FAERS
283AgitationFAERS: 12US FAERS
284Anaphylactoid ReactionFAERS: 12US FAERS
285Arthropod biteFAERS: 12US FAERS
286Dental cariesFAERS: 12US FAERS
287Device breakageFAERS: 12US FAERS
288Emotional distressFAERS: 12US FAERS
289FibromyalgiaFAERS: 12US FAERS
290Gamma-Glutamyltransferase IncreasedFAERS: 12US FAERS
291HepatitisFAERS: 12OFFSIDES
US FAERS
292ImmobileFAERS: 12US FAERS
293Inappropriate schedule of product administrationFAERS: 12US FAERS
294Injection site dischargeFAERS: 12US FAERS
295Musculoskeletal discomfortFAERS: 12OFFSIDES
US FAERS
296Personality ChangeFAERS: 12US FAERS
297Skin indentationFAERS: 12US FAERS
298Trisomy 21FAERS: 12OFFSIDES
US FAERS
299ApathyFAERS: 11OFFSIDES
US FAERS
300Bladder dysfunctionFAERS: 11US FAERS
301Carpal Tunnel SyndromeFAERS: 11US FAERS
302Completed SuicideFAERS: 11OFFSIDES
US FAERS
303EpistaxisFAERS: 11OFFSIDES
US FAERS
304Guillain-Barre SyndromeFAERS: 11US FAERS
305HerniaFAERS: 11
Canada Vigilance: 1
Canada Vigilance
US FAERS
306Impaired work abilityFAERS: 11US FAERS
307IndurationFAERS: 11OFFSIDES
US FAERS
308Multiple sclerosis plaqueFAERS: 11US FAERS
309NoduleFAERS: 11US FAERS
310OsteomyelitisFAERS: 11US FAERS
311PneumothoraxFAERS: 11OFFSIDES
US FAERS
312Renal painFAERS: 11US FAERS
313Restless Legs SyndromeFAERS: 11US FAERS
314Sjogren's SyndromeFAERS: 11US FAERS
315Skin IndurationFAERS: 11US FAERS
316Skin PapillomaFAERS: 11US FAERS
317SluggishnessFAERS: 11US FAERS
318Altered state of consciousnessFAERS: 10US FAERS
319AneurysmFAERS: 10US FAERS
320AtaxiaFAERS: 10OFFSIDES
US FAERS
321ColitisFAERS: 10US FAERS
322CystFAERS: 10US FAERS
323DiverticulitisFAERS: 10US FAERS
324DysphemiaFAERS: 10US FAERS
325EczemaFAERS: 10US FAERS
326Flank PainFAERS: 10US FAERS
327FractureFAERS: 10US FAERS
328HyperventilationFAERS: 10US FAERS
329HypothyroidismFAERS: 10US FAERS
330Incorrect product storageFAERS: 10US FAERS
331Ligament ruptureFAERS: 10OFFSIDES
US FAERS
332Lyme DiseaseFAERS: 10US FAERS
333Maternal exposure before pregnancyFAERS: 10US FAERS
334Medication ErrorFAERS: 10US FAERS
335MenorrhagiaFAERS: 10US FAERS
336Muscle RigidityFAERS: 10US FAERS
337Musculoskeletal chest painFAERS: 10OFFSIDES
US FAERS
338No reaction on previous exposure to drugFAERS: 10US FAERS
339PsoriasisFAERS: 10US FAERS
340Skin tightnessFAERS: 10US FAERS
341ThrombocytopeniaFAERS: 10US FAERS
342VasculitisFAERS: 10US FAERS
343AphoniaFAERS: 9US FAERS
344Arthropod stingFAERS: 9US FAERS
345ClumsinessFAERS: 9US FAERS
346Drug administered at inappropriate siteFAERS: 9US FAERS
347Eye irritationFAERS: 9US FAERS
348Feeling jitteryFAERS: 9US FAERS
349GlioblastomaFAERS: 9
Canada Vigilance: 1
Canada Vigilance
OFFSIDES
US FAERS
350Impaired driving abilityFAERS: 9US FAERS
351Injection site papuleFAERS: 9US FAERS
352MonoparesisFAERS: 9US FAERS
353Oral painFAERS: 9US FAERS
354ParanoiaFAERS: 9US FAERS
355Quality of life decreasedFAERS: 9US FAERS
356RestlessnessFAERS: 9US FAERS
357RetchingFAERS: 9US FAERS
358Spinal fusion surgeryFAERS: 9US FAERS
359Autoimmune thyroiditisFAERS: 8OFFSIDES
US FAERS
360Back disorderFAERS: 8US FAERS
361Body temperature fluctuationFAERS: 8US FAERS
362BradycardiaFAERS: 8US FAERS
363Device use issueFAERS: 8US FAERS
364DiplegiaFAERS: 8US FAERS
365ErysipelasFAERS: 8US FAERS
366Expired product administeredFAERS: 8US FAERS
367Food AllergyFAERS: 8OFFSIDES
US FAERS
368Gastrointestinal infectionFAERS: 8OFFSIDES
US FAERS
369HyperthyroidismFAERS: 8US FAERS
370Injection site lacerationFAERS: 8US FAERS
371Intentional product misuseFAERS: 8US FAERS
372Irritable Bowel SyndromeFAERS: 8US FAERS
373Lack of injection site rotationFAERS: 8US FAERS
374LeukopeniaFAERS: 8US FAERS
375LymphadenitisFAERS: 8US FAERS
376Nerve injuryFAERS: 8US FAERS
377Ocular discomfortFAERS: 8US FAERS
378OverdoseFAERS: 8OFFSIDES
US FAERS
379PanniculitisFAERS: 8OFFSIDES
US FAERS
380ParesisFAERS: 8US FAERS
381PericarditisFAERS: 8OFFSIDES
US FAERS
382Pharyngeal swellingFAERS: 8
Canada Vigilance: 3
Canada Vigilance
US FAERS
383Poor quality sleepFAERS: 8US FAERS
384Post procedural infectionFAERS: 8US FAERS
385Productive CoughFAERS: 8US FAERS
386PurpuraFAERS: 8US FAERS
387Uhthoff's phenomenonFAERS: 8US FAERS
388UlcerFAERS: 8US FAERS
389VIIth nerve paralysisFAERS: 8US FAERS
390Visual disturbanceFAERS: 8OFFSIDES
US FAERS
391furuncleFAERS: 8US FAERS
392AgeusiaFAERS: 7US FAERS
393Angina PectorisFAERS: 7US FAERS
394Application site painFAERS: 7US FAERS
395Basal cell carcinomaFAERS: 7US FAERS
396BlepharospasmFAERS: 7OFFSIDES
US FAERS
397Blood blisterFAERS: 7US FAERS
398Blood pressure fluctuationFAERS: 7US FAERS
399Bowel movement irregularityFAERS: 7US FAERS
400BradyphreniaFAERS: 7US FAERS
401DeformityFAERS: 7
Canada Vigilance: 1
Canada Vigilance
US FAERS
402Device difficult to useFAERS: 7US FAERS
403DroolingFAERS: 7US FAERS
404Drug DependenceFAERS: 7US FAERS
405Drug ToleranceFAERS: 7US FAERS
406Drug administered to patient of inappropriate ageFAERS: 7US FAERS
407Ear discomfortFAERS: 7OFFSIDES
US FAERS
408Exposure via breast milkFAERS: 7US FAERS
409Frustration tolerance decreasedFAERS: 7US FAERS
410GoutFAERS: 7US FAERS
411HepatotoxicityFAERS: 7OFFSIDES
US FAERS
412Inability to afford medicationFAERS: 7US FAERS
413Incorrect route of product administrationFAERS: 7US FAERS
414Injection site exfoliationFAERS: 7US FAERS
415Injection site nerve damageFAERS: 7US FAERS
416Intentional dose omissionFAERS: 7US FAERS
417Intentional product use issueFAERS: 7US FAERS
418Intracranial AneurysmFAERS: 7OFFSIDES
US FAERS
419JC polyomavirus test positiveFAERS: 7US FAERS
420LaryngitisFAERS: 7US FAERS
421Lower respiratory tract infectionFAERS: 7US FAERS
422Meniscus injuryFAERS: 7US FAERS
423Mental status changesFAERS: 7OFFSIDES
US FAERS
424Middle insomniaFAERS: 7US FAERS
425Muscle FatigueFAERS: 7US FAERS
426MydriasisFAERS: 7US FAERS
427MyocarditisFAERS: 7US FAERS
428Nephrotic SyndromeFAERS: 7OFFSIDES
US FAERS
429Pre-EclampsiaFAERS: 7US FAERS
430Pulmonary FibrosisFAERS: 7US FAERS
431RhinitisFAERS: 7US FAERS
432Rotator cuff syndromeFAERS: 7US FAERS
433SplenomegalyFAERS: 7US FAERS
434StomatitisFAERS: 7US FAERS
435Therapeutic product effect decreasedFAERS: 7US FAERS
436ToothacheFAERS: 7US FAERS
437Toxicity to various agentsFAERS: 7US FAERS
438TrismusFAERS: 7US FAERS
439UveitisFAERS: 7
Canada Vigilance: 1
Canada Vigilance
US FAERS
440Wrong scheduleFAERS: 7US FAERS
441muscle injuryFAERS: 7OFFSIDES
US FAERS
442Acute myocardial infarctionFAERS: 6US FAERS
443Amyotrophic Lateral SclerosisFAERS: 6US FAERS
444Blood glucose abnormalFAERS: 6US FAERS
445CardiomegalyFAERS: 6US FAERS
446Carotid artery occlusionFAERS: 6OFFSIDES
US FAERS
447Cervix carcinomaFAERS: 6US FAERS
448Chemical injuryFAERS: 6US FAERS
449Device FailureFAERS: 6US FAERS
450EcchymosisFAERS: 6US FAERS
451Erectile dysfunctionFAERS: 6US FAERS
452Expired drug administeredFAERS: 6US FAERS
453Foaming at mouthFAERS: 6US FAERS
454Gastric ulcerFAERS: 6
Canada Vigilance: 1
Canada Vigilance
OFFSIDES
US FAERS
455Heat ExhaustionFAERS: 6US FAERS
456Heat StrokeFAERS: 6US FAERS
457HemiparaesthesiaFAERS: 6US FAERS
458HepatomegalyFAERS: 6US FAERS
459Hip surgeryFAERS: 6US FAERS
460Injection site fibrosisFAERS: 6US FAERS
461Injection site pustuleFAERS: 6US FAERS
462LeukocytosisFAERS: 6
Canada Vigilance: 1
Canada Vigilance
US FAERS
463LipomaFAERS: 6US FAERS
464Local reactionFAERS: 6US FAERS
465Lymphocyte count decreasedFAERS: 6OFFSIDES
US FAERS
466Manufacturing product shipping issueFAERS: 6US FAERS
467MeningiomaFAERS: 6OFFSIDES
US FAERS
468MeningitisFAERS: 6US FAERS
469Non-cardiac chest painFAERS: 6OFFSIDES
US FAERS
470ParaplegiaFAERS: 6US FAERS
471Pelvic PainFAERS: 6US FAERS
472Pericardial effusionFAERS: 6OFFSIDES
US FAERS
473Retinal DetachmentFAERS: 6US FAERS
474SclerodermaFAERS: 6OFFSIDES
US FAERS
475Stevens-Johnson SyndromeFAERS: 6OFFSIDES
US FAERS
476Subcutaneous AbscessFAERS: 6US FAERS
477Vaginal DischargeFAERS: 6US FAERS
478Vitreous floatersFAERS: 6US FAERS
479Abdominal InfectionFAERS: 5
Canada Vigilance: 1
Canada Vigilance
US FAERS
480Abdominal rigidityFAERS: 5US FAERS
481AsthenopiaFAERS: 5US FAERS
482Autonomic nervous system imbalanceFAERS: 5US FAERS
483Blood creatine phosphokinase increasedFAERS: 5OFFSIDES
US FAERS
484BronchospasmFAERS: 5US FAERS
485BruxismFAERS: 5OFFSIDES
US FAERS
486Cerebral InfarctionFAERS: 5US FAERS
487Cerebral disorderFAERS: 5OFFSIDES
US FAERS
488ChromaturiaFAERS: 5US FAERS
489Coronary Artery DiseaseFAERS: 5US FAERS
490Cytolytic hepatitisFAERS: 5OFFSIDES
US FAERS
491DermatitisFAERS: 5
Canada Vigilance: 2
Canada Vigilance
US FAERS
492Device occlusionFAERS: 5US FAERS
493Diabetes mellitus inadequate controlFAERS: 5US FAERS
494Drug dispensing errorFAERS: 5OFFSIDES
US FAERS
495Drug ineffective for unapproved indicationFAERS: 5US FAERS
496DysenteryFAERS: 5US FAERS
497DystoniaFAERS: 5US FAERS
498EndometriosisFAERS: 5US FAERS
499ExophthalmosFAERS: 5US FAERS
500Expanded disability status scale score increasedFAERS: 5US FAERS
501Extra dose administeredFAERS: 5US FAERS
502Gastric BypassFAERS: 5OFFSIDES
US FAERS
503GastroenteritisFAERS: 5US FAERS
504Gestational DiabetesFAERS: 5US FAERS
505GlaucomaFAERS: 5US FAERS
506Grip strength decreasedFAERS: 5US FAERS
507Hepatic necrosisFAERS: 5OFFSIDES
US FAERS
508Hepatitis CFAERS: 5US FAERS
509Idiosyncratic drug reactionFAERS: 5US FAERS
510Injection site coldnessFAERS: 5US FAERS
511Injection site cystFAERS: 5US FAERS
512Injection site drynessFAERS: 5US FAERS
513Intentional self-injuryFAERS: 5US FAERS
514Intervertebral disc disorderFAERS: 5US FAERS
515Intestinal PerforationFAERS: 5OFFSIDES
US FAERS
516Leukocytoclastic vasculitisFAERS: 5US FAERS
517MastectomyFAERS: 5US FAERS
518Maternal exposure timing unspecifiedFAERS: 5US FAERS
519Optic AtrophyFAERS: 5US FAERS
520Oral candidiasisFAERS: 5US FAERS
521Paranasal sinus discomfortFAERS: 5US FAERS
522Patient dissatisfaction with treatmentFAERS: 5US FAERS
523PiloerectionFAERS: 5US FAERS
524Procedural complicationFAERS: 5US FAERS
525Product formulation issueFAERS: 5US FAERS
526ProteinuriaFAERS: 5US FAERS
527Psychiatric symptomFAERS: 5US FAERS
528QuadriplegiaFAERS: 5US FAERS
529SarcomaFAERS: 5US FAERS
530Secretion dischargeFAERS: 5US FAERS
531Serum SicknessFAERS: 5
Canada Vigilance: 1
Canada Vigilance
US FAERS
532Supraventricular tachycardiaFAERS: 5US FAERS
533Teeth brittleFAERS: 5US FAERS
534Tongue bitingFAERS: 5US FAERS
535TonsillitisFAERS: 5US FAERS
536Upper-airway cough syndromeFAERS: 5US FAERS
537Wound infection staphylococcalFAERS: 5US FAERS
538Accidental overdoseFAERS: 4US FAERS
539Acute kidney injuryFAERS: 4US FAERS
540Acute psychosisFAERS: 4OFFSIDES
US FAERS
541Application site erythemaFAERS: 4US FAERS
542Application site reactionFAERS: 4US FAERS
543Blood amylase increasedFAERS: 4OFFSIDES
US FAERS
544Blood cholesterol increasedFAERS: 4US FAERS
545Blood creatinine increasedFAERS: 4US FAERS
546Blood glucose fluctuationFAERS: 4OFFSIDES
US FAERS
547Blood iron decreasedFAERS: 4US FAERS
548Blood pressure immeasurableFAERS: 4
Canada Vigilance: 1
Canada Vigilance
OFFSIDES
US FAERS
549Blood sodium decreasedFAERS: 4US FAERS
550Breast cancer stage IIFAERS: 4US FAERS
551Cerebral PalsyFAERS: 4US FAERS
552Circumstance or information capable of leading to medication errorFAERS: 4OFFSIDES
US FAERS
553Concomitant disease aggravatedFAERS: 4US FAERS
554Congenital HypothyroidismFAERS: 4OFFSIDES
US FAERS
555Drug specific antibody presentFAERS: 4OFFSIDES
US FAERS
556Ejection Fraction DecreasedFAERS: 4OFFSIDES
US FAERS
557Electrocardiogram abnormalFAERS: 4US FAERS
558EscharFAERS: 4OFFSIDES
US FAERS
559Euphoric moodFAERS: 4US FAERS
560Eye InfectionFAERS: 4US FAERS
561Facial ParesisFAERS: 4US FAERS
562Fat necrosisFAERS: 4US FAERS
563Feeling of body temperature changeFAERS: 4OFFSIDES
US FAERS
564FlatulenceFAERS: 4US FAERS
565GastritisFAERS: 4US FAERS
566Gastrointestinal inflammationFAERS: 4US FAERS
567Head titubationFAERS: 4US FAERS
568Hormone level abnormalFAERS: 4US FAERS
569Human papilloma virus test positiveFAERS: 4US FAERS
570Hypertensive crisisFAERS: 4US FAERS
571IleitisFAERS: 4US FAERS
572Immune thrombocytopenic purpuraFAERS: 4US FAERS
573Impaired gastric emptyingFAERS: 4US FAERS
574IncoherentFAERS: 4US FAERS
575Incorrect storage of drugFAERS: 4US FAERS
576Inflammatory marker increasedFAERS: 4US FAERS
577Intentional drug misuseFAERS: 4OFFSIDES
US FAERS
578Intervertebral Disc DegenerationFAERS: 4US FAERS
579Invasive Ductal Breast CarcinomaFAERS: 4US FAERS
580Large intestine perforationFAERS: 4US FAERS
581LaryngospasmFAERS: 4US FAERS
582Limb massFAERS: 4US FAERS
583Lipase increasedFAERS: 4US FAERS
584Liquid product physical issueFAERS: 4US FAERS
585Lymphocyte count increasedFAERS: 4US FAERS
586LymphopeniaFAERS: 4US FAERS
587Macular degenerationFAERS: 4US FAERS
588Medical device complicationFAERS: 4OFFSIDES
US FAERS
589MetrorrhagiaFAERS: 4US FAERS
590NystagmusFAERS: 4OFFSIDES
US FAERS
591OphthalmoplegiaFAERS: 4
Canada Vigilance: 1
Canada Vigilance
US FAERS
592ParaparesisFAERS: 4OFFSIDES
US FAERS
593Pharmaceutical product complaintFAERS: 4OFFSIDES
US FAERS
594PolyneuropathyFAERS: 4US FAERS
595Product administration errorFAERS: 4US FAERS
596Product dispensing errorFAERS: 4
Canada Vigilance: 1
Canada Vigilance
US FAERS
597Product distribution issueFAERS: 4US FAERS
598Product leakageFAERS: 4US FAERS
599Product use complaintFAERS: 4US FAERS
600Pulmonary thrombosisFAERS: 4US FAERS
601QuadriparesisFAERS: 4US FAERS
602Renal cystFAERS: 4
Canada Vigilance: 1
Canada Vigilance
US FAERS
603Seizure like phenomenaFAERS: 4US FAERS
604Septic ShockFAERS: 4OFFSIDES
US FAERS
605Skin discomfortFAERS: 4US FAERS
606Skin hypertrophyFAERS: 4US FAERS
607Spinal column stenosisFAERS: 4US FAERS
608Tension HeadacheFAERS: 4US FAERS
609Tongue discomfortFAERS: 4US FAERS
610Transmission of drug via semenFAERS: 4OFFSIDES
US FAERS
611TuberculosisFAERS: 4US FAERS
612Venous InjuryFAERS: 4OFFSIDES
US FAERS
613Viral upper respiratory tract infectionFAERS: 4US FAERS
614Vulvovaginal pruritusFAERS: 4US FAERS
615Wound InfectionFAERS: 4US FAERS
616Wound necrosisFAERS: 4US FAERS
617YawningFAERS: 4US FAERS
618Abdominal AbscessFAERS: 3
Canada Vigilance: 1
Canada Vigilance
US FAERS
619Abdominal adhesionsFAERS: 3
Canada Vigilance: 1
Canada Vigilance
US FAERS
620Accidental exposureFAERS: 3US FAERS
621Accidental underdoseFAERS: 3US FAERS
622Administration site bruiseFAERS: 3
Canada Vigilance: 1
Canada Vigilance
US FAERS
623Adnexa uteri painFAERS: 3US FAERS
624Ammonia increasedFAERS: 3US FAERS
625Anaplastic large cell lymphoma T- and null-cell typesFAERS: 3US FAERS
626AngioplastyFAERS: 3US FAERS
627AnhedoniaFAERS: 3US FAERS
628Animal biteFAERS: 3OFFSIDES
US FAERS
629Animal scratchFAERS: 3US FAERS
630Antiphospholipid SyndromeFAERS: 3US FAERS
631AphagiaFAERS: 3US FAERS
632Application site lacerationFAERS: 3US FAERS
633Application site urticariaFAERS: 3US FAERS
634Atrioventricular BlockFAERS: 3US FAERS
635Biliary ColicFAERS: 3US FAERS
636Blister ruptureFAERS: 3US FAERS
637Blood urine presentFAERS: 3OFFSIDES
US FAERS
638Breast cancer recurrentFAERS: 3US FAERS
639Cardiac discomfortFAERS: 3US FAERS
640Central Nervous System InfectionFAERS: 3US FAERS
641Cerebral atrophyFAERS: 3US FAERS
642Cervical dysplasiaFAERS: 3US FAERS
643Chemical burn of skinFAERS: 3US FAERS
644CholestasisFAERS: 3US FAERS
645Chronic gastritisFAERS: 3US FAERS
646ConjunctivitisFAERS: 3US FAERS
647Decreased immune responsivenessFAERS: 3US FAERS
648Device defectiveFAERS: 3US FAERS
649Device dispensing errorFAERS: 3US FAERS
650Device related infectionFAERS: 3US FAERS
651Device use errorFAERS: 3US FAERS
652Drug effect variableFAERS: 3US FAERS
653Drug exposure before pregnancyFAERS: 3OFFSIDES
US FAERS
654Drug withdrawal syndromeFAERS: 3US FAERS
655Ear congestionFAERS: 3US FAERS
656Economic problemFAERS: 3US FAERS
657Electrolyte imbalanceFAERS: 3US FAERS
658EncephaloceleFAERS: 3US FAERS
659EosinophiliaFAERS: 3US FAERS
660Erythema MultiformeFAERS: 3US FAERS
661Eye inflammationFAERS: 3US FAERS
662FrustrationFAERS: 3US FAERS
663Full blood count decreasedFAERS: 3US FAERS
664Gastrointestinal motility disorderFAERS: 3US FAERS
665GingivitisFAERS: 3US FAERS
666GliomaFAERS: 3US FAERS
667Head BangingFAERS: 3OFFSIDES
US FAERS
668HostilityFAERS: 3OFFSIDES
US FAERS
669HungerFAERS: 3US FAERS
670HydrocephalusFAERS: 3
Canada Vigilance: 1
Canada Vigilance
OFFSIDES
US FAERS
671HyperacusisFAERS: 3US FAERS
672Hypoaesthesia facialFAERS: 3US FAERS
673HypoxiaFAERS: 3US FAERS
674IleusFAERS: 3US FAERS
675Implantable defibrillator insertionFAERS: 3US FAERS
676Incision site painFAERS: 3US FAERS
677Increased tendency to bruiseFAERS: 3US FAERS
678Injected limb mobility decreasedFAERS: 3US FAERS
679Injection site eczemaFAERS: 3US FAERS
680Injection site hypertrophyFAERS: 3US FAERS
681Injection site joint painFAERS: 3US FAERS
682Injection site joint swellingFAERS: 3US FAERS
683Injection site lymphadenopathyFAERS: 3US FAERS
684Injection site plaqueFAERS: 3
Canada Vigilance: 1
Canada Vigilance
US FAERS
685Injection site streakingFAERS: 3US FAERS
686Intervertebral disc compressionFAERS: 3US FAERS
687Joint Range of Motion DecreasedFAERS: 3US FAERS
688Limb operationFAERS: 3US FAERS
689LipohypertrophyFAERS: 3US FAERS
690Livedo ReticularisFAERS: 3US FAERS
691Low birth weight babyFAERS: 3US FAERS
692Lung AbscessFAERS: 3OFFSIDES
US FAERS
693Malabsorption from injection siteFAERS: 3
Canada Vigilance: 1
Canada Vigilance
US FAERS
694MastitisFAERS: 3US FAERS
695Maternal exposure during breast feedingFAERS: 3US FAERS
696Mental FatigueFAERS: 3US FAERS
697Metabolic alkalosisFAERS: 3US FAERS
698Myasthenia GravisFAERS: 3US FAERS
699MyoclonusFAERS: 3US FAERS
700Neonatal aspirationFAERS: 3US FAERS
701Neuromyelitis OpticaFAERS: 3OFFSIDES
US FAERS
702Nuchal RigidityFAERS: 3US FAERS
703Obsessive-Compulsive DisorderFAERS: 3US FAERS
704OnychoclasisFAERS: 3US FAERS
705Otitis MediaFAERS: 3US FAERS
706Panic DisorderFAERS: 3OFFSIDES
US FAERS
707PapillomaFAERS: 3US FAERS
708PapuleFAERS: 3US FAERS
709PeriodontitisFAERS: 3US FAERS
710Peripheral venous diseaseFAERS: 3
Canada Vigilance: 1
Canada Vigilance
US FAERS
711PetechiaeFAERS: 3US FAERS
712Physical assaultFAERS: 3US FAERS
713PleurisyFAERS: 3OFFSIDES
US FAERS
714Poor peripheral circulationFAERS: 3US FAERS
715Precancerous cells presentFAERS: 3US FAERS
716Pregnancy of partnerFAERS: 3US FAERS
717Pregnancy on contraceptiveFAERS: 3US FAERS
718PurulenceFAERS: 3US FAERS
719Pyloric StenosisFAERS: 3US FAERS
720Renal Cell CarcinomaFAERS: 3US FAERS
721Renal ColicFAERS: 3OFFSIDES
US FAERS
722Respiratory tract congestionFAERS: 3US FAERS
723RosaceaFAERS: 3US FAERS
724SciaticaFAERS: 3US FAERS
725Sensitivity to weather changeFAERS: 3US FAERS
726Skin ErosionFAERS: 3US FAERS
727Skin texture abnormalFAERS: 3US FAERS
728Somatic symptom disorderFAERS: 3US FAERS
729Status EpilepticusFAERS: 3US FAERS
730SunburnFAERS: 3US FAERS
731SyringomyeliaFAERS: 3US FAERS
732TensionFAERS: 3US FAERS
733Therapeutic product effect incompleteFAERS: 3US FAERS
734Therapeutic response changedFAERS: 3US FAERS
735ThrombocytosisFAERS: 3
Canada Vigilance: 1
Canada Vigilance
US FAERS
736Tissue injuryFAERS: 3US FAERS
737Tooth InfectionFAERS: 3US FAERS
738Tympanic Membrane PerforationFAERS: 3US FAERS
739Upper airway obstructionFAERS: 3US FAERS
740Upper respiratory tract congestionFAERS: 3US FAERS
741Urethral StenosisFAERS: 3US FAERS
742Vascular occlusionFAERS: 3US FAERS
743White blood cell count abnormalFAERS: 3OFFSIDES
US FAERS
744White matter lesionFAERS: 3US FAERS
745Abdominal massFAERS: 2US FAERS
746Abdominal wall infectionFAERS: 2OFFSIDES
US FAERS
747Accidental exposure to product by childFAERS: 2US FAERS
748AdenocarcinomaFAERS: 2OFFSIDES
US FAERS
749Adrenal cystFAERS: 2US FAERS
750AgranulocytosisFAERS: 2US FAERS
751AkinesiaFAERS: 2OFFSIDES
US FAERS
752Alcohol IntoleranceFAERS: 2US FAERS
753Allergic reaction to excipientFAERS: 2US FAERS
754Anal abscessFAERS: 2US FAERS
755AnencephalyFAERS: 2US FAERS
756AnosmiaFAERS: 2US FAERS
757Anti-thyroid antibody positiveFAERS: 2US FAERS
758Antibody test positiveFAERS: 2US FAERS
759AnuriaFAERS: 2US FAERS
760Aortic Valve StenosisFAERS: 2US FAERS
761Application site acneFAERS: 2US FAERS
762Application site papulesFAERS: 2US FAERS
763Application site pruritusFAERS: 2US FAERS
764AscitesFAERS: 2US FAERS
765AstrocytomaFAERS: 2US FAERS
766Auricular swellingFAERS: 2US FAERS
767Benign neoplasm of skinFAERS: 2US FAERS
768Benign neoplasm of thyroid glandFAERS: 2US FAERS
769Bipolar I disorderFAERS: 2US FAERS
770Bladder discomfortFAERS: 2US FAERS
771Bladder spasmFAERS: 2OFFSIDES
US FAERS
772Blood immunoglobulin M increasedFAERS: 2US FAERS
773Blood pressure ambulatory increasedFAERS: 2US FAERS
774Blood thyroid stimulating hormone increasedFAERS: 2US FAERS
775Blood triglycerides increasedFAERS: 2US FAERS
776Bone density decreasedFAERS: 2OFFSIDES
US FAERS
777Brain AbscessFAERS: 2US FAERS
778Brain HypoxiaFAERS: 2US FAERS
779Breast CystFAERS: 2US FAERS
780Bronchial HyperreactivityFAERS: 2US FAERS
781Burning feet syndromeFAERS: 2US FAERS
782BursitisFAERS: 2US FAERS
783Cartilage injuryFAERS: 2OFFSIDES
US FAERS
784Cataract operationFAERS: 2US FAERS
785ChemotherapyFAERS: 2US FAERS
786CholecystitisFAERS: 2US FAERS
787Chronic Spontaneous UrticariaFAERS: 2US FAERS
788Chronic sinusitisFAERS: 2US FAERS
789Clostridium difficile colitisFAERS: 2US FAERS
790Cluster HeadacheFAERS: 2US FAERS
791Coating in mouthFAERS: 2US FAERS
792ColectomyFAERS: 2OFFSIDES
US FAERS
793Complications of maternal exposure to therapeutic drugsFAERS: 2OFFSIDES
US FAERS
794Compression fractureFAERS: 2US FAERS
795Congenital HydrocephalusFAERS: 2US FAERS
796Congenital heart valve disorderFAERS: 2US FAERS
797Consciousness fluctuatingFAERS: 2US FAERS
798Continuous Positive Airway PressureFAERS: 2US FAERS
799Contraindicated product administeredFAERS: 2US FAERS
800Contrast media reactionFAERS: 2US FAERS
801Corneal dystrophyFAERS: 2US FAERS
802Corneal thinningFAERS: 2US FAERS
803Croup infectiousFAERS: 2US FAERS
804Cutaneous sarcoidosisFAERS: 2US FAERS
805DebridementFAERS: 2US FAERS
806Dehydroepiandrosterone decreasedFAERS: 2US FAERS
807DermatomyositisFAERS: 2US FAERS
808Device computer issueFAERS: 2US FAERS
809Device damageFAERS: 2US FAERS
810Device electrical findingFAERS: 2US FAERS
811Diabetic RetinopathyFAERS: 2US FAERS
812Disability assessment scale score decreasedFAERS: 2US FAERS
813DissociationFAERS: 2US FAERS
814Drug exposure via breast milkFAERS: 2OFFSIDES
US FAERS
815Drug prescribing errorFAERS: 2US FAERS
816Drug resistanceFAERS: 2US FAERS
817Drug screen positiveFAERS: 2OFFSIDES
US FAERS
818EmbolismFAERS: 2OFFSIDES
US FAERS
819EncephalitisFAERS: 2OFFSIDES
US FAERS
820Enlarged uvulaFAERS: 2US FAERS
821Epigastric discomfortFAERS: 2US FAERS
822EructationFAERS: 2US FAERS
823Escherichia infectionFAERS: 2US FAERS
824Excessive skinFAERS: 2US FAERS
825Expired device usedFAERS: 2US FAERS
826Extraocular Muscle ParesisFAERS: 2US FAERS
827Extremity necrosisFAERS: 2US FAERS
828Failure to ThriveFAERS: 2US FAERS
829Feeding disorder neonatalFAERS: 2US FAERS
830FibrosisFAERS: 2US FAERS
831Fluid overloadFAERS: 2US FAERS
832Freezing phenomenonFAERS: 2US FAERS
833Gastric infectionFAERS: 2US FAERS
834Gastroenteritis norovirusFAERS: 2US FAERS
835Gastrointestinal PainFAERS: 2US FAERS
836Gastrointestinal carcinomaFAERS: 2US FAERS
837Gastrointestinal hypomotilityFAERS: 2US FAERS
838Gastrointestinal viral infectionFAERS: 2US FAERS
839General physical condition abnormalFAERS: 2US FAERS
840General symptomFAERS: 2OFFSIDES
US FAERS
841Genital HerpesFAERS: 2OFFSIDES
US FAERS
842Genital painFAERS: 2US FAERS
843Gingival RecessionFAERS: 2US FAERS
844GranulocytosisFAERS: 2US FAERS
845HordeolumFAERS: 2US FAERS
846Hyperemesis GravidarumFAERS: 2US FAERS
847HypospadiasFAERS: 2US FAERS
848Idiopathic urticariaFAERS: 2US FAERS
849ImpatienceFAERS: 2US FAERS
850ImpetigoFAERS: 2US FAERS
851Incorrect drug administration durationFAERS: 2US FAERS
852Incorrect drug administration rateFAERS: 2US FAERS
853Infected biteFAERS: 2US FAERS
854Infusion site erythemaFAERS: 2US FAERS
855Initial insomniaFAERS: 2US FAERS
856Injection site dermatitisFAERS: 2US FAERS
857Injection site desquamationFAERS: 2OFFSIDES
US FAERS
858Injection site joint warmthFAERS: 2US FAERS
859Injection site maculeFAERS: 2US FAERS
860Injection site movement impairmentFAERS: 2US FAERS
861Intestinal Pseudo-ObstructionFAERS: 2US FAERS
862Intestinal gangreneFAERS: 2US FAERS
863Intestinal resectionFAERS: 2OFFSIDES
US FAERS
864Intra-abdominal fluid collectionFAERS: 2US FAERS
865Intrathecal pump insertionFAERS: 2US FAERS
866IntussusceptionFAERS: 2US FAERS
867IridocyclitisFAERS: 2US FAERS
868Iron deficiencyFAERS: 2US FAERS
869Joint InstabilityFAERS: 2US FAERS
870Juvenile arthritisFAERS: 2US FAERS
871Laboratory test interferenceFAERS: 2US FAERS
872Left atrial dilatationFAERS: 2US FAERS
873Locked-In SyndromeFAERS: 2US FAERS
874MalnutritionFAERS: 2US FAERS
875Mechanical ventilationFAERS: 2
Canada Vigilance: 1
Canada Vigilance
US FAERS
876MegacolonFAERS: 2OFFSIDES
US FAERS
877MenopauseFAERS: 2US FAERS
878MetamorphopsiaFAERS: 2US FAERS
879MetastasisFAERS: 2US FAERS
880Metastatic NeoplasmFAERS: 2OFFSIDES
US FAERS
881Migraine with AuraFAERS: 2US FAERS
882MoaningFAERS: 2US FAERS
883Muscle necrosisFAERS: 2OFFSIDES
US FAERS
884Mycosis FungoidesFAERS: 2OFFSIDES
US FAERS
885NarcolepsyFAERS: 2US FAERS
886NephritisFAERS: 2US FAERS
887Neurological decompensationFAERS: 2US FAERS
888Nipple inflammationFAERS: 2US FAERS
889Noninfective encephalitisFAERS: 2US FAERS
890Nuclear magnetic resonance imaging spinal abnormalFAERS: 2US FAERS
891ObesityFAERS: 2US FAERS
892Ocular HypertensionFAERS: 2US FAERS
893Open woundFAERS: 2OFFSIDES
US FAERS
894Optic NeuropathyFAERS: 2US FAERS
895Oral infectionFAERS: 2OFFSIDES
US FAERS
896Oral pruritusFAERS: 2US FAERS
897OverweightFAERS: 2US FAERS
898Palmar erythemaFAERS: 2US FAERS
899Pancreatic CystFAERS: 2US FAERS
900PancytopeniaFAERS: 2US FAERS
901PemphigusFAERS: 2OFFSIDES
US FAERS
902PharyngitisFAERS: 2US FAERS
903Pharyngolaryngeal PainFAERS: 2US FAERS
904Physical disabilityFAERS: 2US FAERS
905PlasmapheresisFAERS: 2US FAERS
906PolydactylyFAERS: 2US FAERS
907Polymyalgia RheumaticaFAERS: 2US FAERS
908Poor quality drug administeredFAERS: 2US FAERS
909Precancerous skin lesionFAERS: 2US FAERS
910Premature MenopauseFAERS: 2US FAERS
911Procalcitonin increasedFAERS: 2US FAERS
912Product administered at inappropriate siteFAERS: 2US FAERS
913Product contaminationFAERS: 2US FAERS
914Product contamination physicalFAERS: 2US FAERS
915Product label confusionFAERS: 2US FAERS
916Product preparation errorFAERS: 2US FAERS
917Protein urine presentFAERS: 2US FAERS
918Pulmonary HypertensionFAERS: 2US FAERS
919Pulmonary congestionFAERS: 2US FAERS
920Purulent dischargeFAERS: 2OFFSIDES
US FAERS
921Pyoderma GangrenosumFAERS: 2OFFSIDES
US FAERS
922RadiculopathyFAERS: 2US FAERS
923Reaction to food additiveFAERS: 2US FAERS
924Renal massFAERS: 2US FAERS
925Retinal Vascular DisorderFAERS: 2US FAERS
926Retinal VasculitisFAERS: 2US FAERS
927Retinal vascular occlusionFAERS: 2US FAERS
928RhonchiFAERS: 2US FAERS
929SalpingectomyFAERS: 2US FAERS
930ScleritisFAERS: 2US FAERS
931ScreamingFAERS: 2US FAERS
932Sensation of blood flowFAERS: 2US FAERS
933Sensorimotor disorderFAERS: 2US FAERS
934Sex hormone binding globulin increasedFAERS: 2US FAERS
935Sight disabilityFAERS: 2US FAERS
936Sinus TachycardiaFAERS: 2US FAERS
937Skeletal injuryFAERS: 2US FAERS
938Skin lacerationFAERS: 2US FAERS
939Skin toxicityFAERS: 2US FAERS
940Slow speechFAERS: 2US FAERS
941Solar urticariaFAERS: 2US FAERS
942SomnambulismFAERS: 2US FAERS
943Squamous cell carcinomaFAERS: 2US FAERS
944Staphylococcal abscessFAERS: 2US FAERS
945Staphylococcus test positiveFAERS: 2US FAERS
946Stem cell transplantFAERS: 2US FAERS
947Stiff leg syndromeFAERS: 2US FAERS
948StrabismusFAERS: 2US FAERS
949Stress at workFAERS: 2US FAERS
950Sudden deathFAERS: 2US FAERS
951Superficial vein prominenceFAERS: 2US FAERS
952Suture ruptureFAERS: 2US FAERS
953Symptom recurrenceFAERS: 2US FAERS
954TalipesFAERS: 2OFFSIDES
US FAERS
955TetanyFAERS: 2US FAERS
956Therapeutic product ineffectiveFAERS: 2US FAERS
957Throat cancerFAERS: 2OFFSIDES
US FAERS
958Thrombocytopenic purpuraFAERS: 2US FAERS
959Thyroid hormones increasedFAERS: 2US FAERS
960ThyroiditisFAERS: 2US FAERS
961Tonic posturingFAERS: 2US FAERS
962Tooth ErosionFAERS: 2US FAERS
963Toxic Shock SyndromeFAERS: 2US FAERS
964Traumatic fractureFAERS: 2US FAERS
965Troponin increasedFAERS: 2US FAERS
966Umbilical herniaFAERS: 2US FAERS
967Urethral ObstructionFAERS: 2OFFSIDES
US FAERS
968Urticarial vasculitisFAERS: 2US FAERS
969Vaginal mucosal blisteringFAERS: 2US FAERS
970VasospasmFAERS: 2US FAERS
971Vein collapseFAERS: 2US FAERS
972Ventricular DysfunctionFAERS: 2US FAERS
973Vestibular NeuronitisFAERS: 2US FAERS
974Vibratory sense increasedFAERS: 2US FAERS
975Vulvovaginal adenosisFAERS: 2OFFSIDES
US FAERS
976Vulvovaginal painFAERS: 2US FAERS
977Wound ComplicationFAERS: 2US FAERS
978Wrong product administeredFAERS: 2US FAERS
979abdominal wall woundFAERS: 2US FAERS
980fibromaFAERS: 2US FAERS
981oligodendrogliomaFAERS: 2US FAERS
982Abdominal tendernessFAERS: 1US FAERS
983Abortion completeFAERS: 1US FAERS
984Abortion earlyFAERS: 1US FAERS
985Acanthosis NigricansFAERS: 1US FAERS
986Accidental deathFAERS: 1OFFSIDES
US FAERS
987Acoustic NeuromaFAERS: 1US FAERS
988Acquired gene mutationFAERS: 1US FAERS
989Acute respiratory failureFAERS: 1OFFSIDES
US FAERS
990Acute tonsillitisFAERS: 1US FAERS
991Administration site erythemaFAERS: 1US FAERS
992Administration site indentationFAERS: 1US FAERS
993Administration site noduleFAERS: 1US FAERS
994Administration site reactionFAERS: 1US FAERS
995Administration site thrombosisFAERS: 1US FAERS
996Adrenal massFAERS: 1US FAERS
997Adrenocortical steroid therapyFAERS: 1US FAERS
998Adrenogenital SyndromeFAERS: 1US FAERS
999Agitated depressionFAERS: 1US FAERS
1000AgoraphobiaFAERS: 1US FAERS
1001AlbuminuriaFAERS: 1US FAERS
1002Alcohol abuseFAERS: 1OFFSIDES
US FAERS
1003Alcohol poisoningFAERS: 1OFFSIDES
US FAERS
1004Allergy to arthropod stingFAERS: 1US FAERS
1005Allergy to chemicalsFAERS: 1US FAERS
1006Allergy to synthetic fabricFAERS: 1US FAERS
1007Alopecia AreataFAERS: 1US FAERS
1008AmputationFAERS: 1US FAERS
1009AmyloidosisFAERS: 1US FAERS
1010Anal FissureFAERS: 1US FAERS
1011Anal FistulaFAERS: 1OFFSIDES
US FAERS
1012Anal UlcerFAERS: 1US FAERS
1013Anal sphincter atonyFAERS: 1US FAERS
1014AnisocytosisFAERS: 1OFFSIDES
US FAERS
1015Anorectal discomfortFAERS: 1US FAERS
1016Anorexia NervosaFAERS: 1US FAERS
1017AnorexiaFAERS: 1US FAERS
1018Antibody test abnormalFAERS: 1US FAERS
1019Antinuclear antibody increasedFAERS: 1US FAERS
1020Antipsychotic drug level below therapeuticFAERS: 1US FAERS
1021Aortic occlusionFAERS: 1US FAERS
1022Apallic syndromeFAERS: 1US FAERS
1023Apparent life threatening eventFAERS: 1OFFSIDES
US FAERS
1024Application site burnFAERS: 1US FAERS
1025Application site erosionFAERS: 1US FAERS
1026Application site exfoliationFAERS: 1US FAERS
1027Application site indurationFAERS: 1US FAERS
1028Application site infectionFAERS: 1US FAERS
1029Application site inflammationFAERS: 1US FAERS
1030Arterial InjuryFAERS: 1US FAERS
1031Arteritis obliteransFAERS: 1US FAERS
1032Artificial insemination by partnerFAERS: 1US FAERS
1033AtelectasisFAERS: 1OFFSIDES
US FAERS
1034Atrioventricular Septal DefectFAERS: 1OFFSIDES
US FAERS
1035Atypical pneumoniaFAERS: 1US FAERS
1036AuraFAERS: 1OFFSIDES
US FAERS
1037Autoimmune PancreatitisFAERS: 1US FAERS
1038AversionFAERS: 1US FAERS
1039Axonal neuropathyFAERS: 1US FAERS
1040B-cell lymphoma stage IFAERS: 1US FAERS
1041Bacterial VaginosisFAERS: 1US FAERS
1042Bacterial disease carrierFAERS: 1US FAERS
1043Bacterial test positiveFAERS: 1US FAERS
1044BartholinitisFAERS: 1US FAERS
1045Basal ganglia strokeFAERS: 1US FAERS
1046Bed restFAERS: 1US FAERS
1047Benign NeoplasmFAERS: 1US FAERS
1048Benign anorectal neoplasmFAERS: 1US FAERS
1049Bile Duct StenosisFAERS: 1US FAERS
1050Birth markFAERS: 1US FAERS
1051Bladder neck suspensionFAERS: 1US FAERS
1052Bladder painFAERS: 1US FAERS
1053Bladder prolapseFAERS: 1US FAERS
1054BlepharitisFAERS: 1US FAERS
1055Blood 1,25-dihydroxycholecalciferol decreasedFAERS: 1US FAERS
1056Blood GlucoseFAERS: 1OFFSIDES
US FAERS
1057Blood PressureFAERS: 1US FAERS
1058Blood brain barrier defectFAERS: 1US FAERS
1059Blood copper decreasedFAERS: 1US FAERS
1060Blood corticotrophin abnormalFAERS: 1US FAERS
1061Blood count abnormalFAERS: 1US FAERS
1062Blood creatine phosphokinase MB increasedFAERS: 1US FAERS
1063Blood creatinine abnormalFAERS: 1US FAERS
1064Blood electrolytes decreasedFAERS: 1US FAERS
1065Blood immunoglobulin E increasedFAERS: 1US FAERS
1066Blood immunoglobulin G decreasedFAERS: 1US FAERS
1067Blood insulin decreasedFAERS: 1US FAERS
1068Blood magnesium decreasedFAERS: 1US FAERS
1069Blood potassium increasedFAERS: 1US FAERS
1070Blood pressure inadequately controlledFAERS: 1US FAERS
1071Blood prolactin increasedFAERS: 1US FAERS
1072Body fat disorderFAERS: 1US FAERS
1073BradykinesiaFAERS: 1US FAERS
1074Brain ContusionFAERS: 1US FAERS
1075Breast cancer stage IIIFAERS: 1OFFSIDES
US FAERS
1076Breast engorgementFAERS: 1US FAERS
1077Breast hyperplasiaFAERS: 1US FAERS
1078Breast tendernessFAERS: 1US FAERS
1079Breech PresentationFAERS: 1US FAERS
1080BronchopneumoniaFAERS: 1OFFSIDES
US FAERS
1081Bunion operationFAERS: 1US FAERS
1082Butterfly rashFAERS: 1US FAERS
1083CD4 Lymphocytes DecreasedFAERS: 1OFFSIDES
US FAERS
1084CYP2D6 polymorphismFAERS: 1US FAERS
1085CachexiaFAERS: 1US FAERS
1086Calcification of muscleFAERS: 1US FAERS
1087CalcinosisFAERS: 1US FAERS
1088CandidiasisFAERS: 1US FAERS
1089Carbon dioxide increasedFAERS: 1US FAERS
1090Carcinoma in situ of skinFAERS: 1US FAERS
1091Cardiac HypertrophyFAERS: 1US FAERS
1092Cardiac enzymes increasedFAERS: 1US FAERS
1093Carotid pulse decreasedFAERS: 1US FAERS
1094Cartilage atrophyFAERS: 1US FAERS
1095CatarrhFAERS: 1US FAERS
1096Catheter related complicationFAERS: 1US FAERS
1097Catheter site abscessFAERS: 1US FAERS
1098Catheter site infectionFAERS: 1US FAERS
1099Caustic injuryFAERS: 1US FAERS
1100Cell DeathFAERS: 1US FAERS
1101Cerebellar infarctionFAERS: 1US FAERS
1102Cerebral ventricle dilatationFAERS: 1OFFSIDES
US FAERS
1103Cervical cord compressionFAERS: 1US FAERS
1104CheilitisFAERS: 1US FAERS
1105CholangiocarcinomaFAERS: 1US FAERS
1106CholelithotomyFAERS: 1US FAERS
1107ChromatopsiaFAERS: 1US FAERS
1108Chronic Fatigue SyndromeFAERS: 1US FAERS
1109Chronic Paroxysmal HemicraniaFAERS: 1US FAERS
1110Cleft PalateFAERS: 1US FAERS
1111Clinically isolated syndromeFAERS: 1US FAERS
1112ClonusFAERS: 1US FAERS
1113Clostridium test positiveFAERS: 1US FAERS
1114Coma scale abnormalFAERS: 1US FAERS
1115Complement factor C4 decreasedFAERS: 1US FAERS
1116Congenital brain damageFAERS: 1US FAERS
1117Congenital cerebral cystFAERS: 1US FAERS
1118Contraindicated drug administeredFAERS: 1US FAERS
1119Conversion disorderFAERS: 1US FAERS
1120Cor TriatriatumFAERS: 1US FAERS
1121Corneal ScarFAERS: 1US FAERS
1122Corneal epithelial wrinklingFAERS: 1US FAERS
1123Corneal graft rejectionFAERS: 1US FAERS
1124Corneal lesionFAERS: 1US FAERS
1125Coronary artery embolismFAERS: 1OFFSIDES
US FAERS
1126Cortisol decreasedFAERS: 1US FAERS
1127CraniosynostosisFAERS: 1US FAERS
1128Creutzfeldt-Jakob diseaseFAERS: 1US FAERS
1129Cyst removalFAERS: 1US FAERS
1130Death of relativeFAERS: 1OFFSIDES
US FAERS
1131DeliriumFAERS: 1US FAERS
1132Dental Restoration FailureFAERS: 1US FAERS
1133DependenceFAERS: 1US FAERS
1134Deposit eyeFAERS: 1US FAERS
1135Depression suicidalFAERS: 1US FAERS
1136Dermal absorption impairedFAERS: 1US FAERS
1137Dermatitis HerpetiformisFAERS: 1US FAERS
1138Device deployment issueFAERS: 1US FAERS
1139Device intoleranceFAERS: 1
Canada Vigilance: 1
Canada Vigilance
US FAERS
1140Diabetic KetoacidosisFAERS: 1US FAERS
1141Diabetic metabolic decompensationFAERS: 1US FAERS
1142DiaphragmalgiaFAERS: 1US FAERS
1143Diastolic dysfunctionFAERS: 1OFFSIDES
US FAERS
1144Differential white blood cell count abnormalFAERS: 1US FAERS
1145Dissociative disorderFAERS: 1US FAERS
1146DiverticulumFAERS: 1US FAERS
1147Drug dispensing issueFAERS: 1US FAERS
1148Drug dose omission by deviceFAERS: 1US FAERS
1149Drug effect delayedFAERS: 1US FAERS
1150Drug level above therapeuticFAERS: 1US FAERS
1151Duodenal ulcer perforationFAERS: 1US FAERS
1152DyscheziaFAERS: 1US FAERS
1153DyslexiaFAERS: 1US FAERS
1154DysphasiaFAERS: 1OFFSIDES
US FAERS
1155Dystonic tremorFAERS: 1US FAERS
1156EclampsiaFAERS: 1US FAERS
1157Electrocardiogram ST-T changeFAERS: 1US FAERS
1158ElectrocardiogramFAERS: 1US FAERS
1159Electroencephalogram abnormalFAERS: 1US FAERS
1160Emergency CareFAERS: 1US FAERS
1161Emphysematous bullaFAERS: 1US FAERS
1162Enamel anomalyFAERS: 1US FAERS
1163EndocarditisFAERS: 1US FAERS
1164Endometrial disorderFAERS: 1US FAERS
1165EnuresisFAERS: 1US FAERS
1166Enzyme abnormalityFAERS: 1US FAERS
1167Eosinophilic FasciitisFAERS: 1US FAERS
1168Eosinophilic pleural effusionFAERS: 1US FAERS
1169EpiglottitisFAERS: 1OFFSIDES
US FAERS
1170Epinephrine increasedFAERS: 1US FAERS
1171Epstein-Barr virus antibody positiveFAERS: 1US FAERS
1172Erection increasedFAERS: 1US FAERS
1173Erythema InfectiosumFAERS: 1US FAERS
1174ErythropsiaFAERS: 1US FAERS
1175Escherichia urinary tract infectionFAERS: 1US FAERS
1176Essential HypertensionFAERS: 1US FAERS
1177Exaggerated startle responseFAERS: 1US FAERS
1178Excessive eye blinkingFAERS: 1US FAERS
1179Exfoliative rashFAERS: 1US FAERS
1180Exposure to contaminated deviceFAERS: 1US FAERS
1181ExtravasationFAERS: 1US FAERS
1182Eye allergyFAERS: 1US FAERS
1183Eye laser surgeryFAERS: 1US FAERS
1184Eye opacityFAERS: 1US FAERS
1185Eye symptomFAERS: 1US FAERS
1186Eyelid Function DisorderFAERS: 1US FAERS
1187Eyelid rashFAERS: 1US FAERS
1188False negative investigation resultFAERS: 1US FAERS
1189FasciitisFAERS: 1US FAERS
1190Febrile infectionFAERS: 1US FAERS
1191FibrosarcomaFAERS: 1US FAERS
1192Fine motor delayFAERS: 1US FAERS
1193Fistula repairFAERS: 1US FAERS
1194FolliculitisFAERS: 1US FAERS
1195Food PoisoningFAERS: 1US FAERS
1196Food aversionFAERS: 1OFFSIDES
US FAERS
1197Food cravingFAERS: 1US FAERS
1198FumblingFAERS: 1US FAERS
1199Fungal pharyngitisFAERS: 1US FAERS
1200Gallbladder anomaly congenitalFAERS: 1US FAERS
1201GangreneFAERS: 1OFFSIDES
US FAERS
1202Gastric banding reversalFAERS: 1US FAERS
1203Gastrointestinal bacterial overgrowthFAERS: 1US FAERS
1204Gastrointestinal cancer metastaticFAERS: 1US FAERS
1205Gastrointestinal examinationFAERS: 1US FAERS
1206Gastrointestinal hypermotilityFAERS: 1US FAERS
1207Gastrointestinal mucosal disorderFAERS: 1US FAERS
1208Gastrointestinal obstructionFAERS: 1US FAERS
1209Gastrooesophageal cancerFAERS: 1US FAERS
1210Gaze palsyFAERS: 1US FAERS
1211Gene mutation identification test positiveFAERS: 1US FAERS
1212General physical condition decreasedFAERS: 1US FAERS
1213Genital swellingFAERS: 1US FAERS
1214Genital tract inflammationFAERS: 1US FAERS
1215Glioblastoma MultiformeFAERS: 1OFFSIDES
US FAERS
1216Global AmnesiaFAERS: 1US FAERS
1217GlomerulonephritisFAERS: 1US FAERS
1218GlossitisFAERS: 1US FAERS
1219Gluten sensitivityFAERS: 1US FAERS
1220GranulomaFAERS: 1OFFSIDES
US FAERS
1221Grief reactionFAERS: 1US FAERS
1222HELLP SyndromeFAERS: 1US FAERS
1223HIV test negativeFAERS: 1US FAERS
1224HaematotoxicityFAERS: 1US FAERS
1225Heart sounds abnormalFAERS: 1US FAERS
1226Heavy exposure to ultraviolet lightFAERS: 1US FAERS
1227Hepatitis AFAERS: 1US FAERS
1228Hernia painFAERS: 1US FAERS
1229HidradenitisFAERS: 1US FAERS
1230Hilar lymphadenopathyFAERS: 1US FAERS
1231Hip DysplasiaFAERS: 1US FAERS
1232HirsutismFAERS: 1US FAERS
1233Histamine abnormalFAERS: 1US FAERS
1234Histamine level increasedFAERS: 1US FAERS
1235Hospice CareFAERS: 1US FAERS
1236Human EhrlichiosisFAERS: 1US FAERS
1237HyperkeratosisFAERS: 1US FAERS
1238HyperleukocytosisFAERS: 1US FAERS
1239HyperreflexiaFAERS: 1US FAERS
1240HypertransaminasaemiaFAERS: 1US FAERS
1241Hypertrophic CardiomyopathyFAERS: 1US FAERS
1242HypophagiaFAERS: 1US FAERS
1243HypoventilationFAERS: 1US FAERS
1244Immune Reconstitution Inflammatory SyndromeFAERS: 1US FAERS
1245Immune-mediated adverse reactionFAERS: 1US FAERS
1246Immunoglobulin TherapyFAERS: 1US FAERS
1247Impaired quality of lifeFAERS: 1US FAERS
1248Impaired reasoningFAERS: 1US FAERS
1249Impaired self-careFAERS: 1US FAERS
1250Implant site painFAERS: 1US FAERS
1251Implant site pruritusFAERS: 1US FAERS
1252Incision site complicationFAERS: 1US FAERS
1253Incision site infectionFAERS: 1US FAERS
1254Incision site vesiclesFAERS: 1US FAERS
1255Incorrect disposal of productFAERS: 1US FAERS
1256Increased upper airway secretionFAERS: 1US FAERS
1257InfantFAERS: 1US FAERS
1258InfarctionFAERS: 1US FAERS
1259Infection in an immunocompromised hostFAERS: 1US FAERS
1260Infectious MononucleosisFAERS: 1OFFSIDES
US FAERS
1261InfertilityFAERS: 1US FAERS
1262Infusion site bruisingFAERS: 1US FAERS
1263Infusion site painFAERS: 1US FAERS
1264Infusion site swellingFAERS: 1US FAERS
1265Inguinal massFAERS: 1US FAERS
1266Injection site calcificationFAERS: 1US FAERS
1267Injection site granulomaFAERS: 1US FAERS
1268Injection site joint erythemaFAERS: 1US FAERS
1269Injection site joint infectionFAERS: 1US FAERS
1270Injection site joint movement impairmentFAERS: 1US FAERS
1271Injection site pallorFAERS: 1US FAERS
1272Injection site recall reactionFAERS: 1US FAERS
1273Injection site vasculitisFAERS: 1US FAERS
1274InjectionFAERS: 1US FAERS
1275Instillation site painFAERS: 1US FAERS
1276Insulin-requiring type 2 diabetes mellitusFAERS: 1US FAERS
1277Intercepted drug prescribing errorFAERS: 1US FAERS
1278Intercostal neuralgiaFAERS: 1US FAERS
1279Intervertebral disc injuryFAERS: 1US FAERS
1280Intraductal papillary mucinous neoplasmFAERS: 1US FAERS
1281IritisFAERS: 1OFFSIDES
US FAERS
1282Iron OverloadFAERS: 1US FAERS
1283Itching scarFAERS: 1US FAERS
1284KeratitisFAERS: 1US FAERS
1285KeratoconusFAERS: 1US FAERS
1286Labile blood pressureFAERS: 1US FAERS
1287LabyrinthitisFAERS: 1US FAERS
1288Lactose IntoleranceFAERS: 1US FAERS
1289LeukoencephalomyelitisFAERS: 1OFFSIDES
US FAERS
1290LeukoencephalopathyFAERS: 1US FAERS
1291Lichen PlanusFAERS: 1US FAERS
1292Lid sulcus deepenedFAERS: 1US FAERS
1293Ligament injuryFAERS: 1US FAERS
1294Limb girth increasedFAERS: 1US FAERS
1295Limb prosthesis userFAERS: 1US FAERS
1296Lip and/or oral cavity cancerFAERS: 1US FAERS
1297Lip neoplasm malignant stage unspecifiedFAERS: 1US FAERS
1298LipomatosisFAERS: 1US FAERS
1299Living in residential institutionFAERS: 1US FAERS
1300LordosisFAERS: 1US FAERS
1301Loss of bladder sensationFAERS: 1US FAERS
1302Loss of dreamingFAERS: 1US FAERS
1303Lung InjuryFAERS: 1US FAERS
1304LymphangiomaFAERS: 1US FAERS
1305Lymphangiosis carcinomatosaFAERS: 1US FAERS
1306Lymphatic obstructionFAERS: 1US FAERS
1307Lymphocyte count abnormalFAERS: 1US FAERS
1308LymphocytosisFAERS: 1US FAERS
1309Lymphoid tissue hyperplasiaFAERS: 1US FAERS
1310MYELODYSPLASTIC SYNDROMEFAERS: 1US FAERS
1311Malabsorption from administration siteFAERS: 1US FAERS
1312MalariaFAERS: 1US FAERS
1313Male sexual dysfunctionFAERS: 1US FAERS
1314Malignant HypertensionFAERS: 1US FAERS
1315Malignant melanoma stage IIIFAERS: 1US FAERS
1316Malignant melanoma stage IVFAERS: 1US FAERS
1317Malignant polypFAERS: 1US FAERS
1318Manufacturing product storage issueFAERS: 1US FAERS
1319Mastication disorderFAERS: 1US FAERS
1320MastoiditisFAERS: 1US FAERS
1321Maternal exposure during deliveryFAERS: 1US FAERS
1322Mechanical urticariaFAERS: 1US FAERS
1323Medical device removalFAERS: 1US FAERS
1324Medical induction of comaFAERS: 1US FAERS
1325Medication residue presentFAERS: 1US FAERS
1326MedulloblastomaFAERS: 1US FAERS
1327MeningomyeloceleFAERS: 1US FAERS
1328Meniscus operationFAERS: 1US FAERS
1329MicrocephalyFAERS: 1US FAERS
1330Microvascular AnginaFAERS: 1US FAERS
1331MiliariaFAERS: 1US FAERS
1332Miscarriage of partnerFAERS: 1US FAERS
1333Mite allergyFAERS: 1US FAERS
1334Monocyte count decreasedFAERS: 1US FAERS
1335Morbid thoughtsFAERS: 1OFFSIDES
US FAERS
1336Motion SicknessFAERS: 1US FAERS
1337Multiple MyelomaFAERS: 1US FAERS
1338MumpsFAERS: 1OFFSIDES
US FAERS
1339Muscle contusionFAERS: 1US FAERS
1340Muscle strainFAERS: 1US FAERS
1341MutismFAERS: 1US FAERS
1342Mycobacterium abscessus InfectionFAERS: 1OFFSIDES
US FAERS
1343MyelitisFAERS: 1US FAERS
1344Myocardial calcificationFAERS: 1US FAERS
1345MyopathyFAERS: 1US FAERS
1346MyositisFAERS: 1US FAERS
1347Myotonic DystrophyFAERS: 1US FAERS
1348Nail InfectionFAERS: 1US FAERS
1349Nasal discomfortFAERS: 1
Canada Vigilance: 1
Canada Vigilance
US FAERS
1350Nasal pruritusFAERS: 1US FAERS
1351Natural killer cell count increasedFAERS: 1US FAERS
1352Neonatal pneumoniaFAERS: 1US FAERS
1353Nephritic syndromeFAERS: 1US FAERS
1354NephrocalcinosisFAERS: 1US FAERS
1355Nerve DegenerationFAERS: 1US FAERS
1356Neuralgic AmyotrophyFAERS: 1US FAERS
1357NeuritisFAERS: 1US FAERS
1358NeurodermatitisFAERS: 1US FAERS
1359Neurogenic BowelFAERS: 1US FAERS
1360Neurostimulator implantationFAERS: 1US FAERS
1361Neutropenic colitisFAERS: 1US FAERS
1362Nipple painFAERS: 1US FAERS
1363No adverse effectFAERS: 1US FAERS
1364NocturiaFAERS: 1US FAERS
1365Noonan SyndromeFAERS: 1US FAERS
1366Obsessive thoughtsFAERS: 1US FAERS
1367Occupational exposure to productFAERS: 1US FAERS
1368Ocular icterusFAERS: 1US FAERS
1369Ocular vascular disorderFAERS: 1US FAERS
1370Ocular vasculitisFAERS: 1US FAERS
1371OmphalitisFAERS: 1US FAERS
1372OnychomycosisFAERS: 1US FAERS
1373Ophthalmic vein thrombosisFAERS: 1US FAERS
1374Optic Nerve HypoplasiaFAERS: 1US FAERS
1375Oral fungal infectionFAERS: 1US FAERS
1376Oral mucosal eruptionFAERS: 1US FAERS
1377Oropharyngeal discomfortFAERS: 1US FAERS
1378Oropharyngeal swellingFAERS: 1US FAERS
1379Orthosis userFAERS: 1US FAERS
1380Ossicle disorderFAERS: 1US FAERS
1381OsteochondrosisFAERS: 1US FAERS
1382Osteogenesis ImperfectaFAERS: 1US FAERS
1383OsteomalaciaFAERS: 1US FAERS
1384Ovulation disorderFAERS: 1US FAERS
1385Oxygen saturation abnormalFAERS: 1US FAERS
1386Oxygen supplementationFAERS: 1US FAERS
1387Pancreatic NeoplasmFAERS: 1US FAERS
1388Pancreatic enzymes increasedFAERS: 1US FAERS
1389Paranasal cystFAERS: 1US FAERS
1390Paranasal sinus hypersecretionFAERS: 1US FAERS
1391Paternal exposure timing unspecifiedFAERS: 1US FAERS
1392Pathological fractureFAERS: 1US FAERS
1393Pelvic floor repairFAERS: 1US FAERS
1394Pelvic fluid collectionFAERS: 1US FAERS
1395Penile size reducedFAERS: 1US FAERS
1396Performance status decreasedFAERS: 1OFFSIDES
US FAERS
1397PeriarthritisFAERS: 1US FAERS
1398Pericardial CystFAERS: 1US FAERS
1399PeritonitisFAERS: 1US FAERS
1400Persistent urogenital sinusFAERS: 1US FAERS
1401Personal relationship issueFAERS: 1US FAERS
1402PertussisFAERS: 1US FAERS
1403Phantom painFAERS: 1US FAERS
1404PhlebitisFAERS: 1OFFSIDES
US FAERS
1405PhotodermatosisFAERS: 1US FAERS
1406PhototherapyFAERS: 1US FAERS
1407Physical deconditioningFAERS: 1US FAERS
1408Physical examination abnormalFAERS: 1US FAERS
1409Physical product label issueFAERS: 1US FAERS
1410Pilonidal CystFAERS: 1US FAERS
1411PingueculaFAERS: 1US FAERS
1412Pityriasis RoseaFAERS: 1US FAERS
1413PneumonitisFAERS: 1US FAERS
1414PoisoningFAERS: 1US FAERS
1415PolyarthritisFAERS: 1US FAERS
1416PolychondritisFAERS: 1US FAERS
1417PolyhydramniosFAERS: 1US FAERS
1418Polyneuropathy chronicFAERS: 1US FAERS
1419Polyomavirus test positiveFAERS: 1US FAERS
1420PolyuriaFAERS: 1OFFSIDES
US FAERS
1421PorokeratosisFAERS: 1US FAERS
1422Post procedural bile leakFAERS: 1US FAERS
1423Post procedural discomfortFAERS: 1US FAERS
1424Post procedural feverFAERS: 1US FAERS
1425Post procedural urine leakFAERS: 1US FAERS
1426Post-Traumatic Stress DisorderFAERS: 1US FAERS
1427Post-traumatic neck syndromeFAERS: 1US FAERS
1428Postoperative abscessFAERS: 1US FAERS
1429PosturingFAERS: 1US FAERS
1430Precancerous mucosal lesionFAERS: 1US FAERS
1431Premature baby deathFAERS: 1US FAERS
1432Premenstrual headacheFAERS: 1US FAERS
1433Premenstrual syndromeFAERS: 1US FAERS
1434Prescribed underdoseFAERS: 1US FAERS
1435Primary Biliary CholangitisFAERS: 1US FAERS
1436Procedural site reactionFAERS: 1US FAERS
1437ProctitisFAERS: 1OFFSIDES
US FAERS
1438Product administered to patient of inappropriate ageFAERS: 1
Canada Vigilance: 1
Canada Vigilance
US FAERS
1439Product availability issueFAERS: 1US FAERS
1440Product comminglingFAERS: 1US FAERS
1441Product contamination microbialFAERS: 1US FAERS
1442Product depositFAERS: 1US FAERS
1443Product dropper issueFAERS: 1US FAERS
1444Product expiration date issueFAERS: 1US FAERS
1445Product label issueFAERS: 1US FAERS
1446Product lot number issueFAERS: 1US FAERS
1447Product measured potency issueFAERS: 1US FAERS
1448Product outer packaging issueFAERS: 1US FAERS
1449Product packaging quantity issueFAERS: 1US FAERS
1450Product physical consistency issueFAERS: 1US FAERS
1451Product sterility lackingFAERS: 1US FAERS
1452Product substitutionFAERS: 1US FAERS
1453Product taste abnormalFAERS: 1US FAERS
1454Protein S DeficiencyFAERS: 1US FAERS
1455Protein total increasedFAERS: 1US FAERS
1456Pruritus allergicFAERS: 1US FAERS
1457PseudoparalysisFAERS: 1US FAERS
1458Psychogenic seizureFAERS: 1US FAERS
1459Psychomotor skills impairedFAERS: 1OFFSIDES
US FAERS
1460Pulmonary function test decreasedFAERS: 1US FAERS
1461Pulmonary malformationFAERS: 1US FAERS
1462Pulmonary painFAERS: 1US FAERS
1463Puncture site erythemaFAERS: 1US FAERS
1464Puncture site painFAERS: 1US FAERS
1465PyelonephritisFAERS: 1
Canada Vigilance: 1
Canada Vigilance
US FAERS
1466Pyogenic granulomaFAERS: 1US FAERS
1467Radiation FibrosisFAERS: 1US FAERS
1468Reaction to preservativesFAERS: 1US FAERS
1469Refusal of treatment by relativeFAERS: 1US FAERS
1470Renal cancer metastaticFAERS: 1US FAERS
1471Renal cell carcinoma recurrentFAERS: 1US FAERS
1472Renal embolismFAERS: 1US FAERS
1473Renal tubular acidosisFAERS: 1OFFSIDES
US FAERS
1474Renal tubular disorderFAERS: 1US FAERS
1475Retinal Artery OcclusionFAERS: 1US FAERS
1476Retinal exudatesFAERS: 1OFFSIDES
US FAERS
1477Retrograde amnesiaFAERS: 1US FAERS
1478RhabdomyolysisFAERS: 1US FAERS
1479Rheumatoid factor increasedFAERS: 1US FAERS
1480RhinalgiaFAERS: 1US FAERS
1481Rippling muscle diseaseFAERS: 1US FAERS
1482Rubber sensitivityFAERS: 1US FAERS
1483Saliva alteredFAERS: 1US FAERS
1484Salivary gland painFAERS: 1US FAERS
1485Salpingo-oophorectomyFAERS: 1US FAERS
1486SchizophreniaFAERS: 1US FAERS
1487Selective eating disorderFAERS: 1US FAERS
1488Self MutilationFAERS: 1US FAERS
1489Sense of oppressionFAERS: 1
Canada Vigilance: 1
Canada Vigilance
OFFSIDES
US FAERS
1490Sensory level abnormalFAERS: 1US FAERS
1491SeromaFAERS: 1OFFSIDES
US FAERS
1492Serotonin SyndromeFAERS: 1US FAERS
1493Shock symptomFAERS: 1
Canada Vigilance: 1
Canada Vigilance
US FAERS
1494Sick Sinus SyndromeFAERS: 1US FAERS
1495Silent myocardial infarctionFAERS: 1US FAERS
1496Similar reaction on previous exposure to drugFAERS: 1US FAERS
1497Single umbilical arteryFAERS: 1US FAERS
1498Sinus operationFAERS: 1US FAERS
1499Skin dystrophyFAERS: 1US FAERS
1500Skin noduleFAERS: 1US FAERS
1501Sleep ParalysisFAERS: 1US FAERS
1502Sleep TalkingFAERS: 1US FAERS
1503Sleep disorder due to general medical condition, insomnia typeFAERS: 1US FAERS
1504Slow response to stimuliFAERS: 1US FAERS
1505Small intestine carcinoma metastaticFAERS: 1US FAERS
1506Smear site unspecified abnormalFAERS: 1US FAERS
1507Soft tissue atrophyFAERS: 1US FAERS
1508Solar lentigoFAERS: 1US FAERS
1509Spastic paralysisFAERS: 1US FAERS
1510Spina BifidaFAERS: 1OFFSIDES
US FAERS
1511Spinal column injuryFAERS: 1US FAERS
1512Spinal cord infectionFAERS: 1US FAERS
1513SplenectomyFAERS: 1US FAERS
1514Splenic neoplasm malignancy unspecifiedFAERS: 1US FAERS
1515SpondylitisFAERS: 1US FAERS
1516StaringFAERS: 1US FAERS
1517StridorFAERS: 1US FAERS
1518Subclavian artery thrombosisFAERS: 1US FAERS
1519Subcorneal pustular dermatosisFAERS: 1US FAERS
1520SubileusFAERS: 1US FAERS
1521Sudden onset of sleepFAERS: 1US FAERS
1522Superficial injury of eyeFAERS: 1US FAERS
1523Suppressed lactationFAERS: 1US FAERS
1524Supraventricular tachyarrhythmiaFAERS: 1US FAERS
1525Surgical failureFAERS: 1US FAERS
1526Suspected product contaminationFAERS: 1US FAERS
1527Suspected transmission of an infectious agent via productFAERS: 1US FAERS
1528Swelling of eyelidFAERS: 1
Canada Vigilance: 1
Canada Vigilance
US FAERS
1529Synovial CystFAERS: 1US FAERS
1530Systemic Inflammatory Response SyndromeFAERS: 1US FAERS
1531Systemic lupus erythematosus rashFAERS: 1US FAERS
1532T-Cell LymphomaFAERS: 1OFFSIDES
US FAERS
1533TachyphreniaFAERS: 1US FAERS
1534Temperature regulation disorderFAERS: 1US FAERS
1535TeratomaFAERS: 1US FAERS
1536Terminal stateFAERS: 1US FAERS
1537Testicular massFAERS: 1US FAERS
1538Thalamic infarctionFAERS: 1US FAERS
1539Therapeutic procedureFAERS: 1US FAERS
1540Therapeutic product contaminationFAERS: 1US FAERS
1541ThermohypoaesthesiaFAERS: 1US FAERS
1542Throat clearingFAERS: 1US FAERS
1543ThyroidectomyFAERS: 1US FAERS
1544Tinea CapitisFAERS: 1US FAERS
1545Tinea PedisFAERS: 1US FAERS
1546Tissue irritationFAERS: 1US FAERS
1547Tongue blisteringFAERS: 1US FAERS
1548Tongue spasmFAERS: 1US FAERS
1549Tooth ExtractionFAERS: 1US FAERS
1550Transaminases abnormalFAERS: 1US FAERS
1551Traumatic tooth displacementFAERS: 1US FAERS
1552Trigeminal Nerve DisorderFAERS: 1US FAERS
1553Trigeminal nerve paresisFAERS: 1US FAERS
1554Ultrasound abdomen abnormalFAERS: 1US FAERS
1555Ultrasound liver abnormalFAERS: 1US FAERS
1556UnderweightFAERS: 1US FAERS
1557Unexpected therapeutic drug effectFAERS: 1US FAERS
1558Urge IncontinenceFAERS: 1US FAERS
1559Urinary tract infection fungalFAERS: 1US FAERS
1560Urinary tract infection staphylococcalFAERS: 1US FAERS
1561Urine alcohol test positiveFAERS: 1US FAERS
1562Urine bilirubin increasedFAERS: 1US FAERS
1563Uterine PolypFAERS: 1US FAERS
1564Uterine ProlapseFAERS: 1US FAERS
1565Uterine spasmFAERS: 1US FAERS
1566Vaccination failureFAERS: 1US FAERS
1567Vaginal abscessFAERS: 1US FAERS
1568Vaginal enlargementFAERS: 1US FAERS
1569Vaginal painFAERS: 1US FAERS
1570Varicella virus test positiveFAERS: 1US FAERS
1571Vascular compressionFAERS: 1US FAERS
1572Vascular graft thrombosisFAERS: 1US FAERS
1573Vascular insufficiencyFAERS: 1US FAERS
1574Vascular ruptureFAERS: 1US FAERS
1575Vasculitic rashFAERS: 1US FAERS
1576Venous ThrombosisFAERS: 1US FAERS
1577Venous occlusionFAERS: 1US FAERS
1578Venous perforationFAERS: 1US FAERS
1579Ventricular FibrillationFAERS: 1OFFSIDES
US FAERS
1580Ventricular hypertrophyFAERS: 1US FAERS
1581Ventricular hypokinesiaFAERS: 1US FAERS
1582Vessel perforationFAERS: 1US FAERS
1583Violence-related symptomFAERS: 1US FAERS
1584Viral test positiveFAERS: 1US FAERS
1585Vital functions abnormalFAERS: 1US FAERS
1586Vitamin D DeficiencyFAERS: 1US FAERS
1587Vitreous DetachmentFAERS: 1US FAERS
1588Vulvovaginal discomfortFAERS: 1US FAERS
1589Vulvovaginal inflammationFAERS: 1US FAERS
1590Vulvovaginal mycotic infectionFAERS: 1OFFSIDES
US FAERS
1591Vulvovaginal swellingFAERS: 1US FAERS
1592West Nile viral infectionFAERS: 1US FAERS
1593Winged scapulaFAERS: 1US FAERS
1594Wolff-Parkinson-White SyndromeFAERS: 1US FAERS
1595Wound dehiscenceFAERS: 1US FAERS
1596Wound infection bacterialFAERS: 1US FAERS
1597Wrong drug administeredFAERS: 1US FAERS
1598colonoscopyFAERS: 1OFFSIDES
US FAERS
1599heart rateFAERS: 1US FAERS
1600kyphosisFAERS: 1US FAERS
1601liposarcomaFAERS: 1OFFSIDES
US FAERS
1602ovarian neoplasmFAERS: 1US FAERS
1603prostatitisFAERS: 1US FAERS
1604pseudomembranous colitisFAERS: 1US FAERS
1605skin abrasionFAERS: 1US FAERS
1606Abnormal cervical smearOFFSIDES
1607Abnormal clotting factorOFFSIDES
1608Abnormal visionOFFSIDES
1609AbuseOFFSIDES
1610AgraphiaOFFSIDES
1611Alcohol consumptionOFFSIDES
1612AlveolitisOFFSIDES
1613Angle Closure GlaucomaOFFSIDES
1614Anorectal infectionOFFSIDES
1615Anticholinergic SyndromeOFFSIDES
1616Anticonvulsant drug level increasedOFFSIDES
1617ApneaOFFSIDES
1618Aseptic MeningitisOFFSIDES
1619Atrial tachycardiaOFFSIDES
1620Autoantibody positiveCanada Vigilance: 1Canada Vigilance
1621Bilirubin conjugated increasedOFFSIDES
1622Blood alkaline phosphatase abnormalOFFSIDES
1623Blood immunoglobulin MOFFSIDES
1624Blood thyroid stimulating hormoneOFFSIDES
1625Body TemperatureOFFSIDES
1626BrachydactylyCanada Vigilance: 1Canada Vigilance
1627Brain stem syndromeOFFSIDES
1628Bronchoalveolar LavageOFFSIDES
1629Candidiasis of vaginaOFFSIDES
1630CholangiolitisOFFSIDES
1631Chronic ulcerative colitisOFFSIDES
1632CirrhosisOFFSIDES
1633ConfabulationOFFSIDES
1634Congenital heart diseaseOFFSIDES
1635Congenital intestinal malformationOFFSIDES
1636Congenital syphilitic osteochondritisOFFSIDES
1637Conjunctival depositOFFSIDES
1638Contact DermatitisOFFSIDES
1639Dandy-Walker SyndromeOFFSIDES
1640DiarrheaOFFSIDES
1641Disseminated Intravascular CoagulationOFFSIDES
1642DiverticulosisOFFSIDES
1643Drug toxicityOFFSIDES
1644Drug withdrawal headacheOFFSIDES
1645DysmorphismOFFSIDES
1646Dysthymic DisorderOFFSIDES
1647EpicondylitisOFFSIDES
1648Epstein-Barr virus antigen positiveOFFSIDES
1649Epstein-Barr virus associated lymphoproliferative disorderOFFSIDES
1650Erythema NodosumOFFSIDES
1651Fatty LiverOFFSIDES
1652Focal glomerulosclerosisOFFSIDES
1653Foreign body traumaOFFSIDES
1654Gastrointestinal dysplasiaOFFSIDES
1655GoiterOFFSIDES
1656Guttate psoriasisOFFSIDES
1657HemicephalalgiaOFFSIDES
1658Infection reactivationCanada Vigilance: 1Canada Vigilance
1659Intention tremorOFFSIDES
1660Intraocular inflammationOFFSIDES
1661IridectomyOFFSIDES
1662Irregular breathingCanada Vigilance: 1Canada Vigilance
1663Kidney FailureOFFSIDES
1664Lactation DisorderOFFSIDES
1665LeukoplakiaOFFSIDES
1666LipaseOFFSIDES
1667Liver Cirrhosis17038628CTD
1668LymphangitisOFFSIDES
1669Mediastinal massOFFSIDES
1670MeningoceleOFFSIDES
1671MeningoradiculitisOFFSIDES
1672Milk AllergyOFFSIDES
1673Multiple drug overdoseOFFSIDES
1674Multiple drug overdose intentionalOFFSIDES
1675Muscle WeaknessOFFSIDES
1676MyelodysplasiaOFFSIDES
1677Myoclonic EpilepsyOFFSIDES
1678Non-small cell lung cancer stage IOFFSIDES
1679OligodipsiaOFFSIDES
1680OrthopneaOFFSIDES
1681ParotitisOFFSIDES
1682Peridiverticular abscessOFFSIDES
1683PlasmacytomaOFFSIDES
1684PleocytosisOFFSIDES
1685Poor personal hygieneOFFSIDES
1686PseudolymphomaCanada Vigilance: 1Canada Vigilance
1687Rebound effectOFFSIDES
1688Rheumatic FeverOFFSIDES
1689Septal panniculitisOFFSIDES
1690Sputum culture positiveOFFSIDES
1691Superior Vena Cava SyndromeOFFSIDES
1692SyndactylyCanada Vigilance: 1Canada Vigilance
1693Temporal ArteritisCanada Vigilance: 1Canada Vigilance
OFFSIDES
1694Thromboangiitis ObliteransOFFSIDES
1695Victim of sexual abuseOFFSIDES
1696Virus serology test positiveOFFSIDES
Powered by :

Page last updated at 2020-05-25 10:01:57 (Asia/Shanghai) | You are visitor No. 120234

Copyright © 2019-2020 Laboratory of Molecular Modeling and Design, Shanghai Key Laboratory of New Drug Design, School of Pharmacy, East China University of Science and Technology. All rights reserved.